<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Venom Anim Toxins Incl Trop Dis</journal-id>
<journal-id journal-id-type="iso-abbrev">J Venom Anim Toxins Incl Trop Dis</journal-id>
<journal-id journal-id-type="publisher-id">jvatitd</journal-id>
<journal-title-group>
<journal-title>The Journal of Venomous Animals and Toxins Including Tropical Diseases</journal-title>
</journal-title-group>
<issn pub-type="epub">1678-9199</issn>
<publisher>
<publisher-name>Centro de Estudos de Venenos e Animais Peçonhentos - CEVAP,
Universidade Estadual Paulista - UNESP</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31131004</article-id>
<article-id pub-id-type="pmc">6483409</article-id>
<article-id pub-id-type="other">00202</article-id>
<article-id pub-id-type="doi">10.1590/1678-9199-JVATITD-1481-18</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Scorpion toxins targeting Kv1.3 channels: insights into
immunosuppression</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Oliveira</surname>
<given-names>Isadora S</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ferreira</surname>
<given-names>Isabela G</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alexandre-Silva</surname>
<given-names>Gabriel M</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cerni</surname>
<given-names>Felipe A</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cremonez</surname>
<given-names>Caroline M</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Arantes</surname>
<given-names>Eliane C</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zottich</surname>
<given-names>Umberto</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0003-2594-7068</contrib-id>
<name>
<surname>Pucca</surname>
<given-names>Manuela B</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c1">*</xref>
</contrib>
</contrib-group>
<aff id="aff1">
<label>1</label>School of Pharmaceutical Sciences of Ribeirão Preto, Department of
Physics and Chemistry, University of São Paulo, Ribeirão Preto, SP, Brazil.</aff>
<aff id="aff2">
<label>2</label>Medical School, Federal University of Roraima, Boa Vista, RR,
Brazil.</aff>
<aff id="aff3">
<label>3</label>Ribeirão Preto Medical School, Department of Biochemistry and
Immunology, University of São Paulo, Ribeirão Preto, SP, Brazil.</aff>
<author-notes>
<corresp id="c1"><label>*</label>Correspondence: <email>manu.pucca@ufrr.br</email></corresp>
<fn fn-type="COI-statement" id="fn3">
<p><bold>Competing interests:</bold> Not applicable.</p>
</fn>
<fn fn-type="con" id="fn4">
<p><bold>Authors' contributions:</bold> IGB, GMA, FAC, CMC, ECA and UZ wrote part of the review and provided
critical feedback. ISO presented the major contribution (took the lead in
writing the manuscript). MBP is the corresponding author and designer of the
review. All authors read and approved the final manuscript.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>15</day>
<month>4</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>25</volume>
<elocation-id>e148118</elocation-id>
<history>
<date date-type="received">
<day>30</day>
<month>7</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>10</month>
<year>2018</year>
</date>
</history>
<permissions>
<license license-type="open-access">
<license-p>This article is distributed under the terms of the Creative Commons
Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">
http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits
unrestricted use, distribution, and reproduction in any medium, provided you
give appropriate credit to the original author(s) and the source, provide a
link to the Creative Commons license, and indicate if changes were made. The
Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">
http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to
the data made available in this article, unless otherwise stated.
</license-p>
</license>
</permissions>
<abstract>
<title>Abstract</title>
<p>Scorpion venoms are natural sources of molecules that have, in addition to their
toxic function, potential therapeutic applications. In this source the
neurotoxins can be found especially those that act on potassium channels.
Potassium channels are responsible for maintaining the membrane potential in the
excitable cells, especially the voltage-dependent potassium channels (Kv),
including Kv1.3 channels. These channels (Kv1.3) are expressed by various types
of tissues and cells, being part of several physiological processes. However,
the major studies of Kv1.3 are performed on T cells due its importance on
autoimmune diseases. Scorpion toxins capable of acting on potassium channels
(KTx), mainly on Kv1.3 channels, have gained a prominent role for their possible
ability to control inflammatory autoimmune diseases. Some of these toxins have
already left bench trials and are being evaluated in clinical trials, presenting
great therapeutic potential. Thus, scorpion toxins are important natural
molecules that should not be overlooked in the treatment of autoimmune and other
diseases.</p>
</abstract>
<kwd-group>
<title>Keywords:</title>
<kwd>voltage-gated potassium channels</kwd>
<kwd>Kv1.3</kwd>
<kwd>scorpion toxins</kwd>
<kwd>KTx</kwd>
<kwd>immunosuppression</kwd>
</kwd-group>
<counts>
<fig-count count="2"></fig-count>
<table-count count="1"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="161"></ref-count>
<page-count count="0"></page-count>
</counts>
</article-meta>
</front>
<body>
<sec>
<title>Background</title>
<p>Venomous animals are specialized predators that developed high degree of complexity
compounds for their own biological purposes [<xref ref-type="bibr" rid="B1">1</xref>]. They produced venoms that contain a cocktail of toxins with a great
structural and functional diversity [<xref ref-type="bibr" rid="B2">2</xref>]. In
addition, venom components present diverse characteristics including low-molecular
mass, stability, high potency and selectivity for a wide variety of targets in
mammalian systems [<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>].</p>
<p>Nevertheless, one important advantage of venoms is that they can act on many target
molecules used for therapeutic intervention [<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>]. Therefore, animal venoms are
increasingly recognized as a new emerging source of peptide-based therapeutics
[<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>].</p>
<p>Scorpion venoms are composed of numerous toxins, mostly of peptides and neurotoxins,
which can interfere with all biological systems [<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>]. Moreover, neurotoxins are
known to modify cell membrane ion channels and to cause the release of massive
neurotransmitters and cytokines [<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>]. In this sense, scorpion venoms have been
considered as invaluable resources of ion channel inhibitors and/or modulators, and
potassium channel acting toxins (KTx) are one of the most studied [<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B12">12</xref>-<xref ref-type="bibr" rid="B14">14</xref>].</p>
<p>Voltage-gated potassium channels (Kv) have received much attention because they are
widespread in almost all tissues, besides presenting high expression in mammalian
cells. They are involved in the regulation of many physiological processes,
including heart rate, neuronal excitability, insulin production, epithelial
electrolyte transport, cell proliferation, smooth muscle contraction,
neurotransmitter release and immune response [<xref ref-type="bibr" rid="B15">15</xref>]. In particular, the voltage-gated potassium channel type 1.3 (Kv1.3)
is a well-recognized functional marker and an attractive pharmacological target for
treating autoimmune diseases [<xref ref-type="bibr" rid="B16">16</xref>]. Thus,
based on the interactions between scorpion toxins and potassium channels, a great
effort has been employed to find scorpion toxins selectively acting on the Kv1.3
channels [<xref ref-type="bibr" rid="B17">17</xref>]. It is important to emphasize
that other animals also produce toxins with action on Kv1.3, such as ShK toxin, a
potent Kv1.3 inhibitor obtained from <italic>Stichodactyla helianthus</italic>
Caribbean sea anemone venom, and also named as Dalazatide (its synthetic analog)
[<xref ref-type="bibr" rid="B18">18</xref>]. This first-in-class investigational
drug completed phases Ia and Ib of clinical trials and phase IIa is expected to
start in this year (2018) [<xref ref-type="bibr" rid="B19">19</xref>]. Clinical
studies demonstrated that Dalazatide (Kineta Inc.) can decrease skin lesions of
psoriasis [<xref ref-type="bibr" rid="B20">20</xref>]. Also, this molecule is being
study for bringing novel new therapeutics of other autoimmune diseases (e.g.
multiple sclerosis and rheumatoid arthritis) [<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B22">22</xref>].</p>
<p>This review will present the current state of art regarding scorpion toxins targeting
Kv1.3 channels. Moreover, it will provide details on the Kv1.3 discovery, structure
and function focusing on its important role as a target to induce
immunosuppression.</p>
</sec>
<sec>
<title>Kv1.3 channel discovery and structure</title>
<p>Kv1.3 currents were firstly recorded in both resting and mitogen stimulated human T
lymphocytes in 1984, using patch-clamp technique [<xref ref-type="bibr" rid="B23">23</xref>], although in that time the channel did not received the Kv1.3
nomenclature. In the following year, its biophysical properties were also reported.
Kv1.3 demonstrated to be a delayed rectifier like voltage-gated potassium channel
presenting a slow and very complex mode of inactivation: the lymphocyte
K<sup>+</sup> currents turn on with a sigmoid time course upon the
depolarization and, then inactivate almost completely with voltage dependence and
kinetics that resemble delayed rectifier K<sup>+</sup> channel of muscle and nerve
[<xref ref-type="bibr" rid="B24">24</xref>].</p>
<p>The name Kv1.3 was only introduced in 1991 with a standardized nomenclature [<xref ref-type="bibr" rid="B25">25</xref>]. In that study, researchers demonstrated
through phylogenetic trees that the channel presents a significant structural
homology with the <italic>Shaker</italic> channel from <italic>Drosophila
melanogaster</italic>. Therefore, the Kv1.3 channel was classified as a
mammalian <italic>Shaker</italic>-related voltage-gated potassium channel encoded by
the KCNA3 gene, which is found in humans, rats and mice [<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B26">26</xref>].</p>
<p>The functional channel is formed by four pore loop-containing α-subunits arranged as
a homotetrameric association. Each monomer contains 528 amino acids, six
transmembrane segments (S1 through S6) and one pore region formed by the
interactions of the four homotetramer to create the walls. In this pore, both the
N-terminal and C-terminal domains are located within the cytoplasm [<xref ref-type="bibr" rid="B27">27</xref>].</p>
<p>The N-linked glycosylation site is in the external S1-S2 loop, the channel presents
two protein kinase C sites that are located in the S4-S5 linker and a tyrosine
kinase site in the N-terminal region. The tripeptide sequence motif G(Y/F)G located
in the S5-S6 linker is common to the pore or P loop of these channels and, four of
the pore loop domains contribute to the formation of a functional K<sup>+</sup>
conducting pore [<xref ref-type="bibr" rid="B27">27</xref>-<xref ref-type="bibr" rid="B29">29</xref>].</p>
<p>The transmembrane S4 segment represents the major component of the voltage sensor for
this channel, it contains positively charged residues (like lysine or arginine) at
almost every third portion of its structure [<xref ref-type="bibr" rid="B29">29</xref>].</p>
<p>One interesting approach employed for studying the structure of the Kv1.3 channels is
the use of peptides such as scorpion toxins, for mapping the external vestibule of
the channel. Based on that, a study was conducted using four scorpion toxins that
have the capacity to block the channel (kaliotoxin, charybdotoxin, margatoxin and
noxiustoxin). The authors used mutagenesis in combination with quantitative
analytical methods and, they could identify several channel residues that interact
specifically with toxin residues. These studies revealed the existence of a shallow
(4-6 Å) and wide (35 Å) saucer-shaped external vestibule with the K<sup>+</sup>
channel signature sequence (GYGD) forming a through as its center [<xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B31">31</xref>].</p>
<p>One unique feature of the Kv1.3 external vestibule is the presence of a ring of
histidine ~9-14 Å in diameter, positioned at the outer entrance of the ion
conduction pathway and, none of the so far known Kv channels has a histidine at this
position [<xref ref-type="bibr" rid="B28">28</xref>].</p>
<p>The external entry to the channel pore consisting of portions of the P-loop and
adjacent residues in S5 and S6 segments constitutes possible binding sites for
toxins and K<sup>+</sup> channel blockers. Studies demonstrated that toxins are
observed to lock into the channel selectivity filter through a lysine residue in the
position 27, performing a strong interaction with the channel selectivity filter.
Although most of the toxins bind to the Lys-27, this is not a rule, some interact
differently with the channel peripheral acidic residues such as Glu-420, Asp-423 and
Asp-433, or can even present a different Lys position (Lys-25) [<xref ref-type="bibr" rid="B32">32</xref>-<xref ref-type="bibr" rid="B34">34</xref>].</p>
</sec>
<sec>
<title>Kv1.3 channel role</title>
<p>Kv1.3 channels are molecules expressed in macrophages, microglia cells, natural
killer cells, B and T lymphocytes, osteoclasts, platelets, central nervous system
(CNS), prominent in the olfactory bulb and testis [<xref ref-type="bibr" rid="B35">35</xref>-<xref ref-type="bibr" rid="B38">38</xref>] being able to participate
in numerous physiological processes [<xref ref-type="bibr" rid="B39">39</xref>].
These channels are important for maintaining the negative membrane potential as they
promote intracellular K<sup>+</sup> efflux as well as help in the influx of
extracellular Ca<sup>2+</sup> through Ca<sup>2+</sup> channels activated by the
release of Ca<sup>2+</sup> [<xref ref-type="bibr" rid="B40">40</xref>-<xref ref-type="bibr" rid="B44">44</xref>]. However, this rectifier channel has a
characteristic that differentiates it from the other channels from Kv1 family, which
is its inactivation for long periods (~ 1 minute or more) after repeated
depolarization [<xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B46">46</xref>]. Blockage of these channels may bring improvements related
to homeostasis regulation, as well as to the immune system [<xref ref-type="bibr" rid="B43">43</xref>, <xref ref-type="bibr" rid="B47">47</xref>]. Therefore, mice
that have the absence of these channels (knockout animals or
Kv1.3<sup>-</sup>/<sup>-</sup>) present variation on signaling molecules levels,
such as postsynaptic density protein 95 (PSD-95) and tropomyosin receptor kinase B
(TrKB) [<xref ref-type="bibr" rid="B48">48</xref>], as well as, there is a decrease
of some markers, such as somatostatin and neuropeptide Y interneurons, and an
increase of parvalbumin on the cerebral cortex [<xref ref-type="bibr" rid="B45">45</xref>]. Moreover, these murine model presents neuroprotection against
experimental autoimmune encephalomyelitis (EAE) and increases the levels of
interleukin-10 (IL-10) production [<xref ref-type="bibr" rid="B49">49</xref>],
besides the expression of high levels of forkhead box protein O1 (FoxO1),
phosphospecific signal transducer and activator of transcription 5 (pSTAT5),
cytotoxic T-lymphocyte-associated protein 4 (CTLA4), erythroid transcription factor
(GATA1) and interleukin-2 receptor alpha chain (CD25) [<xref ref-type="bibr" rid="B50">50</xref>]. On the other hand, Kv1.3<sup>-/-</sup> rats show that
maximal T-cell responses against autoantigen or repeated tetanus toxoid stimulations
require both Kv1.3 and KCa3.1, since knockdown of Kv1.3 rats developed
adjuvant-induced arthritis (AIA) in a manner similar to WT rats, indicating that
there were no defects in T-cell activation [<xref ref-type="bibr" rid="B51">51</xref>].</p>
<p>In addition, it has already been shown that Kv1.3<sup>-</sup>/<sup>-</sup> mice are
able to discriminate odors, as well as, they present high olfactory function, being
thus named "super-smellers" [<xref ref-type="bibr" rid="B48">48</xref>]. It was also
found that these mice were resistant to obesity when induced by a moderately
high-fat diet [<xref ref-type="bibr" rid="B52">52</xref>, <xref ref-type="bibr" rid="B53">53</xref>]. They had irregular intake, as well as their metabolic
activities, increased locomotion during the dark cycle and behaviors similar to
hyperactivity [<xref ref-type="bibr" rid="B48">48</xref>, <xref ref-type="bibr" rid="B54">54</xref>]. Recent studies have shown that the same mice model present
exacerbated behaviors related to anxiety, in addition to being inattentive [<xref ref-type="bibr" rid="B55">55</xref>].</p>
<p>Although this phenotype causes all these differences, it has been observed that
Kv1.3<sup>-</sup>/<sup>-</sup> animals do not present anomalies in lymphocytes,
both in number and type, in T cell proliferation and in thymocyte apoptosis, which
may be related to the compensatory increase of the chloride current, maintaining the
negative membrane potential [<xref ref-type="bibr" rid="B56">56</xref>].</p>
<p>In addition to these animal models, there are several pathological conditions where
the dysregulation of Kv1.3 occurs [<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B57">57</xref>, <xref ref-type="bibr" rid="B58">58</xref>].
The list below presents an onset of diseases in which Kv1.3 participates in their
pathology (i.e. they are important for cells involved):</p>
<p>
<list list-type="bullet"><list-item><p>Allergic contact dermatitis: skin disease T-cell mediated, as a delayed
hypersensitivity reaction (type IV). In this pathology there is an
increase of T<sub>EM</sub> cells T-effector memory lymphocytes
(T<sub>EM</sub>) [<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B59">59</xref>];</p></list-item><list-item><p>Alopecia areata: an autoimmune disease that acts against the hair
follicle, which is surrounded by T and natural killer (NK) cells, and
T<sub>EM</sub> cells [<xref ref-type="bibr" rid="B39">39</xref>,
<xref ref-type="bibr" rid="B60">60</xref>-<xref ref-type="bibr" rid="B62">62</xref>];</p></list-item><list-item><p>Asthma: pathology characterized as chronic inflammation of the airways,
caused by infectious or environmental stimuli, leading to reversible
bronchoconstriction and presenting an increase of leukocytes [<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B63">63</xref>];</p></list-item><list-item><p>Atherosclerosis: chronic inflammatory disease in which the innate and
adaptive immune responses are activated, forming fatty streaks and the
Kv1.3 channels being necessary for the foam cells [<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B64">64</xref>];
</p></list-item><list-item><p>Breast cancer: one of the most common types of cancer among females, but
there are still controversies regarding Kv1.3 channels, which may be
increased or decreased in tumors [<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B65">65</xref>];</p></list-item><list-item><p>Chronic lymphocytic leukemia: type of chronic leukemia which there is an
exacerbated production of B cells, with Kv1.3 channels being very
expressed in cell membranes and mitochondria and, when inhibited, leads
to cellular apoptosis [<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B66">66</xref>, <xref ref-type="bibr" rid="B67">67</xref>];</p></list-item><list-item><p>Chronic renal failure: loss of renal function, which occurs with chronic
inflammation, with the proliferation of leukocytes in the kidneys that
express large amounts of Kv1.3 channels [<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B68">68</xref>];</p></list-item><list-item><p>Cognitive disabilities: this terminology is given to people who have some
deficit of attention, perception, memory, conceptualization, perception,
learning disabilities, autism, dyslexia among others related problems
[<xref ref-type="bibr" rid="B69">69</xref>]. With the inhibition of
Kv1.3 channels, an improvement in the symptoms of this disabilities is
observed [<xref ref-type="bibr" rid="B39">39</xref>];</p></list-item><list-item><p>Crohn’s disease: chronic inflammation of the gastrointestinal system, in
which there is an increase of T<sub>EM</sub> cells [<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B70">70</xref>];</p></list-item><list-item><p>Multiple sclerosis: disease mediated by immune system, causing damage to
the CNS, such as loss of axons and demyelination [<xref ref-type="bibr" rid="B41">41</xref>, <xref ref-type="bibr" rid="B71">71</xref>]. In
this pathology there is an increase of T<sub>EM</sub> cells [<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B39">39</xref>];</p></list-item><list-item><p>Muscle sarcomas: type of muscular system cancer, which Kv1.3 channels are
expressed in tumors and this expression may be related to its severity
[<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B72">72</xref>];</p></list-item><list-item><p>Obesity: disease associated with human behavior, which the individual
presents binge eating and inhibition of Kv1.3 channels led to an
increase in insulin sensitivity [<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B73">73</xref>].</p></list-item><list-item><p>Prostate cancer: type of cancer that is closely related to male death and
Kv1.3 channels are poorly expressed in these tumors, thus, there is an
inverse correlation of this channel expression and the aggressiveness of
the cancer [<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B74">74</xref>].</p></list-item><list-item><p>Psoriasis: a skin disease of chronic and recurrent character, presenting
a proliferative increase of the epidermis, as well as its inflammation
[<xref ref-type="bibr" rid="B75">75</xref>]. In this pathology there
is an increase of T<sub>EM</sub> cells [<xref ref-type="bibr" rid="B39">39</xref>];</p></list-item><list-item><p>Rheumatoid arthritis: chronic inflammatory autoimmune disease of the
joints and may be accompanied by inflammation in other organs that are
not articulated or other chronic symptoms, and, in this pathology, there
is an increase of T<sub>EM</sub> cells [<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B76">76</xref>];</p></list-item><list-item><p>Systemic lupus erythematosus: autoimmune disease, which chronic
inflammation is present, as well as innate and adaptive immune
responses. In this pathology there are several symptoms and an increase
of T<sub>EM</sub> cells [<xref ref-type="bibr" rid="B39">39</xref>,
<xref ref-type="bibr" rid="B64">64</xref>];</p></list-item><list-item><p>Type I diabetes mellitus: pathological and autoimmune conditions mediated
by T<sub>EM</sub> cells. In this pathology the destruction of pancreatic
β-cells occurs [<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B77">77</xref>];</p></list-item><list-item><p>Type II diabetes mellitus: type of diabetes resistant to insulin and
causes hyperglycemia, and when there is inhibition of Kv1.3 channels, an
increase in insulin sensitivity occurs [<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B78">78</xref>];</p></list-item><list-item><p>Ulcerative colitis: chronic inflammation of the gastrointestinal system,
being that in the colon and rectum. There is exacerbated activity of T
lymphocytes (CD4<sup>+</sup> and CD8<sup>+</sup>), which express Kv1.3
channels [<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B70">70</xref>];</p></list-item><list-item><p>Vasculitis: chronic inflammation that occurs in the vessel wall, which
can affect the lumen as well as cause necrosis and ischemia of the same
[<xref ref-type="bibr" rid="B79">79</xref>]. In this kind of
inflammation, T<sub>EM</sub> cells are involved [<xref ref-type="bibr" rid="B39">39</xref>].</p></list-item></list>
</p>
<p>Therefore, based on the importance of Kv1.3 in different diseases, the channel has
become an important target to novel drug design. </p>
</sec>
<sec>
<title>Kv1.3 channel and T cell regulation</title>
<p>Although many cells express Kv1.3, the most advanced studies with this channel are
related to T cells. The mechanism that makes Kv1.3 channels important to T cells is
directly related to intracellular calcium signaling (<xref ref-type="fig" rid="f1">Fig. 1</xref>). Cellular depolarization increases calcium influx, a process
that is counterbalanced by Kv1.3 channel opening, which repolarizes the cell and
restores calcium through the calcium-release-activated-calcium channel (CRAC).
Calcium signaling is also attenuated by the elimination of cytoplasmic cation by
Ca<sup>2+</sup> ATP-dependent endoplasmic reticulum (SERCA, sarco/endoplasmatic
reticulum Ca<sup>2+</sup> ATPase) and plasma membrane (PMCA, plasma membrane
Ca<sup>2+</sup> ATPase) pumps. PMCA pump is activated by increasing the
concentration of intracellular Ca<sup>2+</sup>. Mitochondria play a double role in
maintaining signaling via calcium: (<italic>i</italic>) it can sequester or store
large amounts of Ca<sup>2+</sup> from the cytoplasm through a single calcium channel
(MCU, mitochondrial Ca<sup>2+</sup> uniporter); (<italic>ii</italic>) MCU can still
sequester the Ca<sup>2+</sup> ions, inhibiting the negative regulation of CRAC
channels [<xref ref-type="bibr" rid="B80">80</xref>]. All the calcium influx allows
the nuclear factor of activated T cells (NFAT) to translocate to the nucleus and
initiate transcription, leading to IL-2 cytokine secretion, a cytokine required for
lymphocyte activation and proliferation [<xref ref-type="bibr" rid="B81">81</xref>,
<xref ref-type="bibr" rid="B82">82</xref>]. Thus, in the absence of sufficient
Ca<sup>2+</sup> influx via CRAC, T lymphocyte activation, proliferation, and
effector functions are completely compromised, as demonstrated by a rare type of
human immunodeficiency [<xref ref-type="bibr" rid="B83">83</xref>, <xref ref-type="bibr" rid="B84">84</xref>].</p>
<p>
<fig id="f1" orientation="portrait" position="float"><label>Figure 1.</label><caption><title>Kv1.3 and Ca<sup>+2</sup> signaling in T cells. Depolarization of the
T cells (about -60 mV) reduces the driving force for Ca<sup>+2</sup>
entry through calcium-release-activated calcium (CRAC) channels, which
is counteracted by the opening of Kv1.3 channels. On the other hand, IK1
(intermediate conductance calcium-activated potassium channel protein 1)
channels open in response to Ca<sup>+2</sup> influx and increased
intracellular Ca<sup>+2</sup> concentration. Ca<sup>+2</sup> are
diminished by the ATP-dependent Ca<sup>+2</sup> pumps - SERCA
(sarco/endoplasmic reticulum Ca<sup>+2</sup> ATPase) and PMCA (plasma
membrane Ca<sup>+2</sup> ATPase). PMCA is activated by increases in
intracellular Ca<sup>+2</sup> signals. Mitochondria can take up and
store large amounts of Ca<sup>+2</sup> from the cytoplasm using MCU
(mitochondrial Ca<sup>+2</sup> uniporter) or it can sequester
Ca<sup>+2</sup> locally. Iinositol-1,4,5-trisphosphate receptor
(InsP3R) can also senses Ca<sup>+2</sup> waves and enhance intracellular
Ca<sup>+2</sup> levels. Blue solid lines represent the pathways that
enhance intracellular Ca<sup>+2</sup> levels. Red dashed lines represent
the pathways that reduce intracellular Ca<sup>+2</sup> levels. Black
dashed line represents K<sup>+</sup> efflux. </title></caption><graphic xlink:href="1678-9199-jvatitd-25-e148118-gf1"></graphic></fig>
</p>
<p>All T cell types express Kv1.3, depending on their state of activation and
differentiation [<xref ref-type="bibr" rid="B71">71</xref>]. According to cellular
activation and homing, T cells can be classified into different phenotypes (<xref ref-type="fig" rid="f2">Fig. 2</xref>): naive T cell, effector T cell and memory
T cell. In addition, memory T cells may exhibit four different phenotypes: stem
memory T cells (T<sub>SCM</sub>), central memory T cells (T<sub>CM</sub>),
T<sub>EM</sub> and tissue resident memory T cells (T<sub>RM</sub>) [<xref ref-type="bibr" rid="B85">85</xref>]. However, Kv1.3 channels have a greater
expression and, consequently, a greater importance on effector memory T cells or
T<sub>EM</sub>. Naïve cells and T<sub>CM</sub> (CD4<sup>+</sup> and
CD8<sup>+</sup>) express 400 to 500 Kv1.3/cell. In contrast, T<sub>EM</sub>
cells express 1,500 Kv1.3/cell. In relation to the other potassium channel expressed
in T cells, the potassium channel activated by calcium (KCa3.1), different numbers
are observed: naive T and T<sub>CM</sub>: 200 to 500 KCa3.1/cell; T<sub>EM</sub>: 10
KCa3.1/cell) [<xref ref-type="bibr" rid="B41">41</xref>, <xref ref-type="bibr" rid="B86">86</xref>, <xref ref-type="bibr" rid="B87">87</xref>]. Thus, although
both potassium channels (Kv1.3 and KCa3.1) are responsible for intracellular
potassium signaling, differences in channel/cell numbers center the importance of
the Kv1.3 channel for T<sub>EM</sub> cells [<xref ref-type="bibr" rid="B88">88</xref>].</p>
<p>
<fig id="f2" orientation="portrait" position="float"><label>Figure 2.</label><caption><title>T cell subsets generation according to cellular activation and
homing. T cells can be differentiated in different populations according
to antigen exposure. Moreover, these T cells can be localized in
different tissues (lymphoid and peripheral tissues). T<sub>SCM:</sub>
stem memory T cell. T<sub>CM:</sub> central memory T cell.
T<sub>EM:</sub> effector memory T cell. T<sub>RM:</sub> tissue
resident memory T cell. Solid lines represent elucidated mechanism of
differentiation. Dashed lines represent mechanisms still unclear.
</title></caption><graphic xlink:href="1678-9199-jvatitd-25-e148118-gf2"></graphic></fig>
</p>
<p>Knowing that T<sub>EM</sub> cells are responsible for the development of autoimmune
diseases, the studies with modulation of Kv1.3 channels have mightily intensified
aiming new therapies using this receptor as target. Furthermore, because Kv1.3
channels are expressed in higher amounts only in T<sub>EM</sub> cells, this targeted
therapy would not impair the naïve or T<sub>CM</sub> responses [<xref ref-type="bibr" rid="B41">41</xref>, <xref ref-type="bibr" rid="B89">89</xref>,
<xref ref-type="bibr" rid="B90">90</xref>].</p>
</sec>
<sec>
<title>Kv1.3 channel scorpion toxins’ blockers</title>
<p>Some scorpion venom toxins have the property of interacting specifically with
K<sup>+</sup> channels and are named as KTx [<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B91">91</xref>]. These toxins comprise a
group of peptides having 23 to 64 amino acid residues, and may contain from three to
four disulfide bonds [<xref ref-type="bibr" rid="B92">92</xref>]. According to their
structure, amino acid sequence and disulfide bonds, these toxins can be classified,
such as α, β, ε, κ, γ and λ-KTx [<xref ref-type="bibr" rid="B91">91</xref>-<xref ref-type="bibr" rid="B94">94</xref>].</p>
<p>Kumenskov and colleagues created a database that presents toxins that interact with K
channels (kaliumdb.org). In that database there are 319 animal toxins, which, 174
are derived from scorpion venom. However, only 81 toxins are capable of interacting
with the Kv1.3 channels (<xref ref-type="table" rid="t1">Table1</xref>) [<xref ref-type="bibr" rid="B95">95</xref>]. Although they present different
affinities, we can define their potential to be considered a <italic>bona
fide</italic> blocker by comparing them to the potency of Dalazatide, which
presents an EC<sub>50</sub> &lt; 100 pM [<xref ref-type="bibr" rid="B96">96</xref>].</p>
<p>
<table-wrap id="t1" orientation="portrait" position="float"><label>Table 1.</label><caption><title>Scorpion toxins targeting K<sub>v</sub>1.3 channels.</title></caption><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th align="left" colspan="1" rowspan="1">Toxin</th><th align="center" colspan="1" rowspan="1">Classification</th><th align="center" colspan="1" rowspan="1">Scorpion specie</th><th align="center" colspan="1" rowspan="1">Modification</th><th align="left" colspan="1" rowspan="1">Assay/Cell type</th><th align="center" colspan="1" rowspan="1">K<sub>d</sub>/IC<sub>50</sub>/EC<sub>50</sub>
(nM)</th><th align="center" colspan="1" rowspan="1">Reference</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Aam-KTX</td><td align="center" colspan="1" rowspan="1">α-KTx 3.12</td><td align="center" colspan="1" rowspan="1">
<italic>Androctonus amoreuxi</italic>
</td><td align="center" colspan="1" rowspan="1">Kaliotoxin analog</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with
<italic>Xenopus leaves</italic> oocytes</td><td align="center" colspan="1" rowspan="1">1.1</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B97">97</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">ADWX-1*</td><td align="center" colspan="1" rowspan="1">α-KTx</td><td align="center" colspan="1" rowspan="1">
<italic>B. martensii</italic>
</td><td align="center" colspan="1" rowspan="1">Recombinant</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with HEK293
cells</td><td align="center" colspan="1" rowspan="1">0.001</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B98">98</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">AgTX-1</td><td align="center" colspan="1" rowspan="1">α-KTx 3.4</td><td align="center" colspan="1" rowspan="1">
<italic>L. quinuqestriatus var. hebraeus</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with HEK293
cells</td><td align="center" colspan="1" rowspan="1">1.7</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B99">99</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">AgTX-2</td><td align="center" colspan="1" rowspan="1">α-KTx 3.2</td><td align="center" colspan="1" rowspan="1">
<italic>L. quinuqestriatus var. hebraeus</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with
<italic>Xenopus</italic> oocytes/ <italic>In vitro</italic>
L929 mouse fibroblast and Human T-lymphocytes</td><td align="center" colspan="1" rowspan="1">0.004</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B99">99</xref>, <xref ref-type="bibr" rid="B100">100</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Anuroctoxin*</td><td align="center" colspan="1" rowspan="1">α-KTx 6.12</td><td align="center" colspan="1" rowspan="1">
<italic>Anuroctonus phaiodactylus</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with human
peripheral T lymphocytes</td><td align="center" colspan="1" rowspan="1">0.73</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B101">101</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">BmK86*</td><td align="center" colspan="1" rowspan="1">α-KTx 26.1</td><td align="center" colspan="1" rowspan="1">
<italic>Mesobuthus martensii</italic> Karsch</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with COS7 cells
cells</td><td align="center" colspan="1" rowspan="1">150</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B102">102</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">BmKTT-1</td><td align="center" colspan="1" rowspan="1">δ-KTx 2.4</td><td align="center" colspan="1" rowspan="1">
<italic>Buthus martensii</italic>
</td><td align="center" colspan="1" rowspan="1">Recombinant</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with HEK293
cells</td><td align="center" colspan="1" rowspan="1">129.7</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B103">103</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">BmKTT-2</td><td align="center" colspan="1" rowspan="1">δ-KTx 3.1</td><td align="center" colspan="1" rowspan="1">
<italic>Buthus martensii</italic>
</td><td align="center" colspan="1" rowspan="1">Recombinant</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with HEK293
cells</td><td align="center" colspan="1" rowspan="1">371.3</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B103">103</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">BmKTT-3</td><td align="center" colspan="1" rowspan="1">δ-KTx 1.2</td><td align="center" colspan="1" rowspan="1">
<italic>Buthus martensii</italic>
</td><td align="center" colspan="1" rowspan="1">Recombinant</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with HEK293
cells</td><td align="center" colspan="1" rowspan="1">&gt; 1000</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B103">103</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">BmKTX*</td><td align="center" colspan="1" rowspan="1">α-KTx</td><td align="center" colspan="1" rowspan="1">
<italic>B. martensi Karsch</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with HEK293
cells</td><td align="center" colspan="1" rowspan="1">0.09</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B104">104</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">BmP01</td><td align="center" colspan="1" rowspan="1">α-KTx 8.2</td><td align="center" colspan="1" rowspan="1">
<italic>Mesobuthus martensii</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with
<italic>Xenopus leaves</italic> oocytes</td><td align="center" colspan="1" rowspan="1">133.72</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B105">105</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">BmP02</td><td align="center" colspan="1" rowspan="1">α-KTx 9.1</td><td align="center" colspan="1" rowspan="1">
<italic>Mesobuthus martensii</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with
<italic>Xenopus</italic> oocytes</td><td align="center" colspan="1" rowspan="1">7</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B106">106</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">BmP03</td><td align="center" colspan="1" rowspan="1">α-KTx 9.2</td><td align="center" colspan="1" rowspan="1">
<italic>Mesobuthus martensii</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with
<italic>Xenopus</italic> oocytes</td><td align="center" colspan="1" rowspan="1">85.4</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B106">106</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">BmTX1</td><td align="center" colspan="1" rowspan="1">α-KTx 1.5</td><td align="center" colspan="1" rowspan="1">
<italic>Buthus martensii</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with
<italic>Xenopus</italic> oocytes</td><td align="center" colspan="1" rowspan="1">1.5</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B107">107</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">BmTX2</td><td align="center" colspan="1" rowspan="1">α-KTx 1.6</td><td align="center" colspan="1" rowspan="1">
<italic>Buthus martensii</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with
<italic>Xenopus</italic> oocytes</td><td align="center" colspan="1" rowspan="1">1.6</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B107">107</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">BoiTx1</td><td align="center" colspan="1" rowspan="1">α-KTx 3.10</td><td align="center" colspan="1" rowspan="1">
<italic>Buthus occitanus israelis</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with
<italic>Xenopus leaves</italic> oocytes</td><td align="center" colspan="1" rowspan="1">3.5</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B108">108</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">BuTX</td><td align="center" colspan="1" rowspan="1">α-KTx 12.2</td><td align="center" colspan="1" rowspan="1">
<italic>Tityus trivittatus</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with
<italic>Xenopus leaves</italic> oocytes</td><td align="center" colspan="1" rowspan="1">0.55</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B109">109</xref>, <xref ref-type="bibr" rid="B110">110</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Ce1*</td><td align="center" colspan="1" rowspan="1">α-KTx 2.8</td><td align="center" colspan="1" rowspan="1">
<italic>Centruroides elegans</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with human T
lymphocytes</td><td align="center" colspan="1" rowspan="1">0.7</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B111">111</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Ce2*</td><td align="center" colspan="1" rowspan="1">α-KTx 2.9</td><td align="center" colspan="1" rowspan="1">
<italic>Centruroides elegans</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with human T
lymphocytes</td><td align="center" colspan="1" rowspan="1">0.25</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B111">111</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Ce3</td><td align="center" colspan="1" rowspan="1">α-KTx 2.10</td><td align="center" colspan="1" rowspan="1">
<italic>Centruroides elegans</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with human T
lymphocytes</td><td align="center" colspan="1" rowspan="1">366</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B111">111</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Ce4*</td><td align="center" colspan="1" rowspan="1">α-KTx 2.11</td><td align="center" colspan="1" rowspan="1">
<italic>Centruroides elegans</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with human T
lymphocytes</td><td align="center" colspan="1" rowspan="1">0.98</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B111">111</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Ce5</td><td align="center" colspan="1" rowspan="1">α-KTx 2.12</td><td align="center" colspan="1" rowspan="1">
<italic>Centruroides elegans</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with human T
lymphocytes</td><td align="center" colspan="1" rowspan="1">69</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B111">111</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Charybdotoxin</td><td align="center" colspan="1" rowspan="1">α-KTx 1.1</td><td align="center" colspan="1" rowspan="1">
<italic>L. quinquestriatus hebraeus</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with mammalian
cell line that presents cloned Kv1.3 channels</td><td align="center" colspan="1" rowspan="1">2.6</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B112">112</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">CoTx1</td><td align="center" colspan="1" rowspan="1">α-KTx 10.1</td><td align="center" colspan="1" rowspan="1">
<italic>Centruroides noxius</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with Rat brain
synaptosomes</td><td align="center" colspan="1" rowspan="1">5.3</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B113">113</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Css20*</td><td align="center" colspan="1" rowspan="1">α-KTx 2.13</td><td align="center" colspan="1" rowspan="1">
<italic>Centruroides suffusus suffuses</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with human
peripheral T lymphocytes</td><td align="center" colspan="1" rowspan="1">7.2</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B114">114</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Ctri18*</td><td align="center" colspan="1" rowspan="1">α-KTx 15</td><td align="center" colspan="1" rowspan="1">
<italic>Chaerilus tricostatus</italic>
</td><td align="center" colspan="1" rowspan="1">Recombinant</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with HEK293
cells</td><td align="center" colspan="1" rowspan="1">ND</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B115">115</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Ctri9577*</td><td align="center" colspan="1" rowspan="1">α-KTx 15.10</td><td align="center" colspan="1" rowspan="1">
<italic>Chaerilus tricostatus</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with HEK293
cells</td><td align="center" colspan="1" rowspan="1">0.49</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B116">116</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Ctry2908*</td><td align="center" colspan="1" rowspan="1">α-KTx 15</td><td align="center" colspan="1" rowspan="1">
<italic>Chaerilus tryznai</italic>
</td><td align="center" colspan="1" rowspan="1">Recombinant</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with HEK293
cells</td><td align="center" colspan="1" rowspan="1">ND</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B115">115</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Ctry68*</td><td align="center" colspan="1" rowspan="1">α-KTx 15</td><td align="center" colspan="1" rowspan="1">
<italic>Chaerilus tryznai</italic>
</td><td align="center" colspan="1" rowspan="1">Recombinant</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with HEK293
cells</td><td align="center" colspan="1" rowspan="1">ND</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B115">115</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Hemitoxin</td><td align="center" colspan="1" rowspan="1">α-KTx 6.15</td><td align="center" colspan="1" rowspan="1">
<italic>Hemiscorpius lepturus</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with
<italic>Xenopus</italic> oocytes</td><td align="center" colspan="1" rowspan="1">2</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B117">117</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Hetlaxin*</td><td align="center" colspan="1" rowspan="1">Data not shown</td><td align="center" colspan="1" rowspan="1">
<italic>Heterometrus laoticus</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Competitive binding experiments with chimeric
KcsA-Kv1.3</td><td align="center" colspan="1" rowspan="1">410</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B118">118</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">HeTx204</td><td align="center" colspan="1" rowspan="1">κ-KTx 2.8</td><td align="center" colspan="1" rowspan="1">
<italic>Heterometrus petersii</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with HEK293
cells</td><td align="center" colspan="1" rowspan="1">ND</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B119">119</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Hg1*</td><td align="center" colspan="1" rowspan="1">δ-KTx 1.1</td><td align="center" colspan="1" rowspan="1">
<italic>Hadrurus gertschi</italic>
</td><td align="center" colspan="1" rowspan="1">Recombinant</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with HEK293
cells</td><td align="center" colspan="1" rowspan="1">6.2</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B103">103</xref>,
<xref ref-type="bibr" rid="B120">120</xref>, <xref ref-type="bibr" rid="B121">121</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Hongotoxin</td><td align="center" colspan="1" rowspan="1">α-KTx 2.5</td><td align="center" colspan="1" rowspan="1">
<italic>Centruroides limbatus</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Inhibition of <sup>86</sup>Rb<sup>+</sup> flux in
HEK293 cells</td><td align="center" colspan="1" rowspan="1">0.086</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B122">122</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">HsTx1<sup>#</sup>
</td><td align="center" colspan="1" rowspan="1">α-KTx 6.3</td><td align="center" colspan="1" rowspan="1">
<italic>Heterometrus spinnifer</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with L929 cells/
<italic>In vivo</italic> assay using DTH reaction, Lewis rat
/ <italic>In vivo</italic> assay using Pristane-induced
arthritis model, Dark Agouti rats</td><td align="center" colspan="1" rowspan="1">0.011</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B123">123</xref>,
<xref ref-type="bibr" rid="B124">124</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">HsTx1[R14A]*</td><td align="center" colspan="1" rowspan="1">Data not shown</td><td align="center" colspan="1" rowspan="1">
<italic>Heterometrus spinnifer</italic>
</td><td align="center" colspan="1" rowspan="1">Synthetic peptide</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with L929
cells</td><td align="center" colspan="1" rowspan="1">0.027</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B124">124</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">ImKtx1*</td><td align="center" colspan="1" rowspan="1">λ-KTx 1.1</td><td align="center" colspan="1" rowspan="1">
<italic>Isometrus maculates</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with HEK293
cells</td><td align="center" colspan="1" rowspan="1">1700</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B125">125</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">ImKTX88*<sup>#</sup>
</td><td align="center" colspan="1" rowspan="1">α-KTx</td><td align="center" colspan="1" rowspan="1">
<italic>Isometrus maculates</italic>
</td><td align="center" colspan="1" rowspan="1">Recombinant</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with HEK293 cells/
<italic>In vivo</italic> experimental autoimmune
encephalomyelitis mice</td><td align="center" colspan="1" rowspan="1">0.091</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B126">126</xref>,
<xref ref-type="bibr" rid="B127">127</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">J123*</td><td align="center" colspan="1" rowspan="1">α-KTx 11.5</td><td align="center" colspan="1" rowspan="1">
<italic>Buthus martensii Karsch</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with HEK293
cells</td><td align="center" colspan="1" rowspan="1">0.79</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B128">128</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Kaliotoxin<sup>#</sup>
</td><td align="center" colspan="1" rowspan="1">α-KTx 3.1</td><td align="center" colspan="1" rowspan="1">
<italic>Androctonus mauretanicus mauretanicus</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with mammalian
cell line that presents cloned Kv1.3 channels/ <italic>In
vivo</italic> rat periodontal disease model</td><td align="center" colspan="1" rowspan="1">0.65</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B112">112</xref>,
<xref ref-type="bibr" rid="B129">129</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Kbot1</td><td align="center" colspan="1" rowspan="1">α-KTx 9.5</td><td align="center" colspan="1" rowspan="1">
<italic>Buthus occitanus tunetanus</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with
<italic>Xenopus</italic> oocytes</td><td align="center" colspan="1" rowspan="1">15</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B130">130</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">κ-Hefutoxin1</td><td align="center" colspan="1" rowspan="1">κ-KTx 1.1</td><td align="center" colspan="1" rowspan="1">
<italic>Heterometrus fulvipes</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with
<italic>Xenopus leaves</italic> oocytes</td><td align="center" colspan="1" rowspan="1">40000</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B131">131</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">LmKTT-1a</td><td align="center" colspan="1" rowspan="1">δ-KTx 2.1</td><td align="center" colspan="1" rowspan="1">
<italic>Lychas mucronatus</italic>
</td><td align="center" colspan="1" rowspan="1">Recombinant</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with HEK293
cells</td><td align="center" colspan="1" rowspan="1">&gt; 1000</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B103">103</xref>,
<xref ref-type="bibr" rid="B132">132</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">LmKTT-1b</td><td align="center" colspan="1" rowspan="1">δ-KTx 2.2</td><td align="center" colspan="1" rowspan="1">
<italic>Lychas mucronatus</italic>
</td><td align="center" colspan="1" rowspan="1">Recombinant</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with HEK293
cells</td><td align="center" colspan="1" rowspan="1">&gt; 1000</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B103">103</xref>,
<xref ref-type="bibr" rid="B132">132</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">LmKTT-1c</td><td align="center" colspan="1" rowspan="1">δ-KTx 2.3</td><td align="center" colspan="1" rowspan="1">
<italic>Lychas mucronatus</italic>
</td><td align="center" colspan="1" rowspan="1">Recombinant</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with HEK293
cells</td><td align="center" colspan="1" rowspan="1">&gt; 1000</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B103">103</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">LmKTx10*</td><td align="center" colspan="1" rowspan="1">α-KTx 12.5</td><td align="center" colspan="1" rowspan="1">
<italic>Lychas mucronatus</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with HEK293
cells</td><td align="center" colspan="1" rowspan="1">28</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B133">133</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">LmKTx8*</td><td align="center" colspan="1" rowspan="1">α-KTx 11.4</td><td align="center" colspan="1" rowspan="1">
<italic>Lychas mucronatus</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with COS7
cells</td><td align="center" colspan="1" rowspan="1">26.4</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B134">134</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Margatoxin*<sup>#</sup>
</td><td align="center" colspan="1" rowspan="1">α-KTx 2.2</td><td align="center" colspan="1" rowspan="1">
<italic>Centruroides margaritatus</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with human
peripheral T lymphocytes/ I<italic>n vitro</italic> human lung
cancer A549/ <italic>In vivo</italic>-xenograft assay, nude
mice</td><td align="center" colspan="1" rowspan="1">~0.030</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B135">135</xref>,
<xref ref-type="bibr" rid="B136">136</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Maurotoxin</td><td align="center" colspan="1" rowspan="1">α-KTx 6.2</td><td align="center" colspan="1" rowspan="1">
<italic>Scorpio maurus palmatus</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with L929
cells</td><td align="center" colspan="1" rowspan="1">155</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B123">123</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">MegKTx3</td><td align="center" colspan="1" rowspan="1">α-KTx 16.7</td><td align="center" colspan="1" rowspan="1">
<italic>Mesobuthus gibbosus</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with
<italic>Xenopus leaves</italic> oocytes</td><td align="center" colspan="1" rowspan="1">118.3</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B137">137</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">MeuKTx-1*</td><td align="center" colspan="1" rowspan="1">α-KTx 8.6</td><td align="center" colspan="1" rowspan="1">
<italic>Mesobuthus eupeus</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with
<italic>Xenopus leaves</italic> oocytes</td><td align="center" colspan="1" rowspan="1">2.36</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B105">105</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">MeuKTx-3</td><td align="center" colspan="1" rowspan="1">α-KTx 3.13</td><td align="center" colspan="1" rowspan="1">
<italic>Mesobuthus eupeus</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with
<italic>Xenopus</italic> oocytes</td><td align="center" colspan="1" rowspan="1">0.171</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B138">138</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">MeuKTx-4*</td><td align="center" colspan="1" rowspan="1">α-KTx 16.4</td><td align="center" colspan="1" rowspan="1">
<italic>Mesobuthus eupeus</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with
<italic>Xenopus leaves</italic> oocytes</td><td align="center" colspan="1" rowspan="1">ND</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B139">139</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">MTX-HsTX1</td><td align="center" colspan="1" rowspan="1">α-KTx 6</td><td align="center" colspan="1" rowspan="1">
<italic>Scorpio maurus palmatus</italic> and
<italic>Heterometrus spinnifer</italic>
</td><td align="center" colspan="1" rowspan="1">Chimera using maurotoxin and HsTX1 toxins</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with L929
cells</td><td align="center" colspan="1" rowspan="1">4</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B123">123</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Noxiustoxin</td><td align="center" colspan="1" rowspan="1">α-KTx 2.1</td><td align="center" colspan="1" rowspan="1">
<italic>Centruroides noxius</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with mammalian
cell line that presents cloned Kv1.3 channels</td><td align="center" colspan="1" rowspan="1">1</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B112">112</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">OcyKTx2</td><td align="center" colspan="1" rowspan="1">α-KTx 6.17</td><td align="center" colspan="1" rowspan="1">
<italic>Opisthacanthus cayaporum</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with human
peripheral T lymphocytes</td><td align="center" colspan="1" rowspan="1">17.7</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B140">140</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">OdK2*</td><td align="center" colspan="1" rowspan="1">α-KTx 3.1</td><td align="center" colspan="1" rowspan="1">
<italic>Odonthobuthus doriae</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with
<italic>Xenopus leaves</italic> oocytes</td><td align="center" colspan="1" rowspan="1">7.2</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B141">141</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">OmTx1</td><td align="center" colspan="1" rowspan="1">κ-KTx 2.1</td><td align="center" colspan="1" rowspan="1">
<italic>Opisthacanthus madagascariensis</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with
<italic>Xenopus leaves</italic> oocytes</td><td align="center" colspan="1" rowspan="1">ND</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B142">142</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">OmTx2</td><td align="center" colspan="1" rowspan="1">κ-KTx 2.2</td><td align="center" colspan="1" rowspan="1">
<italic>Opisthacanthus madagascariensis</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with
<italic>Xenopus leaves</italic> oocytes</td><td align="center" colspan="1" rowspan="1">ND</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B142">142</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">OmTx3</td><td align="center" colspan="1" rowspan="1">κ-KTx 2.3</td><td align="center" colspan="1" rowspan="1">
<italic>Opisthacanthus madagascariensis</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with
<italic>Xenopus leaves</italic> oocytes</td><td align="center" colspan="1" rowspan="1">ND</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B142">142</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">OsK1<sup>#</sup>
</td><td align="center" colspan="1" rowspan="1">α-KTx 3.7</td><td align="center" colspan="1" rowspan="1">
<italic>Orthochirus scrobiculosus</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with L929 and
murine erythroleukaemia cells/ <italic>In vivo</italic>
neurotoxicity assay, C57/BL6 mice </td><td align="center" colspan="1" rowspan="1">0.014</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B143">143</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">PBTx1</td><td align="center" colspan="1" rowspan="1">α-KTx 11.1</td><td align="center" colspan="1" rowspan="1">
<italic>Parabuthus villosus</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with
<italic>Xenopus</italic> oocytes</td><td align="center" colspan="1" rowspan="1">ND</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B144">144</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">PBTx3</td><td align="center" colspan="1" rowspan="1">α-KTx 1.10</td><td align="center" colspan="1" rowspan="1">
<italic>Parabuthus transvaalicus</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with
<italic>Xenopus leaves</italic> oocytes</td><td align="center" colspan="1" rowspan="1">492</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B144">144</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">PEG-HsTX1[R14A]*</td><td align="center" colspan="1" rowspan="1">Data not shown</td><td align="center" colspan="1" rowspan="1">
<italic>Heterometrus spinnifer</italic>
</td><td align="center" colspan="1" rowspan="1">PEGylated molecule</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with L929
cells</td><td align="center" colspan="1" rowspan="1">35.9</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B140">124</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Pi1*</td><td align="center" colspan="1" rowspan="1">α-KTx 6.1</td><td align="center" colspan="1" rowspan="1">
<italic>Pandinus imperator</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with human
lymphocytes</td><td align="center" colspan="1" rowspan="1">9.7</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B145">145</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Pi2*</td><td align="center" colspan="1" rowspan="1">α-KTx 7.1</td><td align="center" colspan="1" rowspan="1">
<italic>Pandinus imperator</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with human
lymphocytes</td><td align="center" colspan="1" rowspan="1">0.05</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B145">145</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Pi3*</td><td align="center" colspan="1" rowspan="1">α-KTx 7.2</td><td align="center" colspan="1" rowspan="1">
<italic>Pandinus imperator</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with human
lymphocytes</td><td align="center" colspan="1" rowspan="1">0.5</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B145">145</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">StKTx23*</td><td align="center" colspan="1" rowspan="1">α-KTx 30.1</td><td align="center" colspan="1" rowspan="1">
<italic>Scorpiops margerisonae</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with HEK293
cells</td><td align="center" colspan="1" rowspan="1">ND</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B119">119</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Tc30</td><td align="center" colspan="1" rowspan="1">α-KTx 4.4</td><td align="center" colspan="1" rowspan="1">
<italic>Tityus cambridgei</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with T
lymphocytes</td><td align="center" colspan="1" rowspan="1">16</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B146">146</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Tc32</td><td align="center" colspan="1" rowspan="1">α-KTx 18.1</td><td align="center" colspan="1" rowspan="1">
<italic>Tityus cambridgei</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with T
lymphocytes</td><td align="center" colspan="1" rowspan="1">10</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B146">146</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Ts6<sup>#</sup>
</td><td align="center" colspan="1" rowspan="1">α-KTx 12.1</td><td align="center" colspan="1" rowspan="1">
<italic>Tityus serrulatus</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with
<italic>Xenopus leaves</italic> oocytes / <italic>In
vivo</italic> assay using DTH reaction, BALB/c mice</td><td align="center" colspan="1" rowspan="1">0.55</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B34">34</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Ts7</td><td align="center" colspan="1" rowspan="1">α-KTx 4.1</td><td align="center" colspan="1" rowspan="1">
<italic>Tityus serrulatus</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with
<italic>Xenopus leaves</italic> oocytes</td><td align="center" colspan="1" rowspan="1">ND</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B34">34</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Ts15<sup>#</sup>
</td><td align="center" colspan="1" rowspan="1">α-KTx 21.1</td><td align="center" colspan="1" rowspan="1">
<italic>Tityus serrulatus</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with
<italic>Xenopus leaves</italic> oocytes / <italic>In
vivo</italic> assay using DTH reaction, BALB/c mice</td><td align="center" colspan="1" rowspan="1">508 1073</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B147">147</xref>,
<xref ref-type="bibr" rid="B148">148</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Tst26*</td><td align="center" colspan="1" rowspan="1">α-KTx 4.6</td><td align="center" colspan="1" rowspan="1">
<italic>Tityus stigmurus</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with human
peripheral T lymphocytes</td><td align="center" colspan="1" rowspan="1">10.7</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B149">149</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Tt28</td><td align="center" colspan="1" rowspan="1">α-KTx 20.1</td><td align="center" colspan="1" rowspan="1">
<italic>Tityus trivittatus</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with
<italic>Xenopus leaves</italic> oocytes</td><td align="center" colspan="1" rowspan="1">7.9</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B150">150</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Urotoxin</td><td align="center" colspan="1" rowspan="1">α-KTx 6.21</td><td align="center" colspan="1" rowspan="1">
<italic>Urodacus yaschenkoi</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with human
peripheral T lymphocytes</td><td align="center" colspan="1" rowspan="1">91</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B151">151</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Vm23*</td><td align="center" colspan="1" rowspan="1">α-KTx 23.2</td><td align="center" colspan="1" rowspan="1">
<italic>Vaejovis mexicanus smithi</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with human
peripheral T lymphocytes</td><td align="center" colspan="1" rowspan="1">10</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B152">152</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Vm24*<sup>#</sup>
</td><td align="center" colspan="1" rowspan="1">α-KTx 23.1</td><td align="center" colspan="1" rowspan="1">
<italic>Vaejovis mexicanus smithi</italic>
</td><td align="center" colspan="1" rowspan="1">
</td><td align="left" colspan="1" rowspan="1">Electrophysiological experiments with human
peripheral T lymphocytes/ <italic>In vivo</italic> assay using
DTH reaction, Lewis rats</td><td align="center" colspan="1" rowspan="1">0.0029</td><td align="center" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="B33">33</xref>]</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>*Selectivity for Kv1.3 channels (toxins unknown action on other
channels)</p></fn><fn id="TFN2"><label><sup>#</sup></label><p> Presented <italic>in vivo</italic> assays</p></fn><fn id="TFN3"><p>EC<sub>50</sub>: half maximal effective concentration</p></fn><fn id="TFN4"><p>IC<sub>50</sub>: half maximal inhibitory concentration</p></fn><fn id="TFN5"><p>K<sub>d</sub>: dissociation constant</p></fn><fn id="TFN6"><p>ND: not-determined</p></fn></table-wrap-foot></table-wrap>
</p>
</sec>
<sec>
<title>Kv1.3 channels and their therapeutic implications</title>
<p>After presenting an in-depth view regarding Kv1.3 channel structure, function and
mechanism on the immunological system, along with a list of all known scorpion
toxins targeting this channel, this section will demonstrate channel effectiveness
as a therapeutic approach. Although many scorpion toxins presented selective
capacity to block Kv1.3 channels, most of them were only evaluated using <italic>in
vitro</italic> tests (e.g. voltage clamp with two microelectrodes, patch-clamp,
etc). Therefore, even though they can be classified as a potential candidate to
therapeutic use, no evidence was reported <italic>in vivo</italic> and/or in humans.
Thence, these toxins will not constitute the focus of this discussion. Below are
presented few examples and a discussion supporting scorpion toxins that block Kv1.3
channel and present proof of concept <italic>in vivo</italic>.</p>
<p>An association was established between the expression of potassium channels, the
proliferation and survival of oncotic cells. Nevertheless, it is not clear if these
channels can participate in the angiogenic stimulation, checkpoint approval during
mitosis or other mechanisms involved. Even though, it was observed that Kv1.3
channels overexpression leads to tumoral cell growth. Based on that, a trial facing
A549 cell line (human lung adenocarcinoma) <italic>in vitro</italic> using
margatoxin (toxin from <italic>Centruroides margaritatus</italic> scorpion venom)
was done, resulting in suppression of lung carcinoma, achieving a significant
blockage of the tumor grown and even a reduction on its volume. Another approach
applied margatoxin into a xenograft model using nude mice and the toxin caused a
reduction of tumor volume when it was injected into the tumor tissues [<xref ref-type="bibr" rid="B135">135</xref>, <xref ref-type="bibr" rid="B136">136</xref>, <xref ref-type="bibr" rid="B153">153</xref>].</p>
<p>A very promising toxin is OsK1 from <italic>Orthochirus scrobiculosus</italic>
scorpion venom<italic>,</italic> more specially its synthesizable mutated form,
which allows to improve its characteristic of being more specific to Kv1.3 than to
Kv1.1 and 1.2 channels. The toxin has been tested <italic>in vitro</italic> upon
L929 and murine erythroleukaemia (MEL) cells stably expressing mouse Kv1.3 (mKv1.3),
Kv3.1 (mKv3.1), human Kv1.5 (hKv1.5) channels and COS7 cells, as well as using
<italic>in vivo</italic> assays in C57/BL6 mice. These assays demonstrated a
high inhibitory effect of the peptide and its analogues on Kv1.3 channels.
Therefore, due to the inborn potential and the possibility of versatile analogues,
OsK1 is considered an important peptide for the development of immunosuppressive
drugs [<xref ref-type="bibr" rid="B143">143</xref>].</p>
<p>Knowing that Kv1.3 channel holds an essential role to regulate ions and function of
immunological cells, theoretically, any peptide capable of suppressing the Kv1.3
channel is a potential therapeutic option for diseases that require
immunosuppression. Thus, different trials have been conducted to define if the
suppression of this channel could lead to selective immunosuppression resulting in
benefits to a patient with autoimmune inflammatory diseases [<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B149">149</xref>, <xref ref-type="bibr" rid="B154">154</xref>, <xref ref-type="bibr" rid="B155">155</xref>].</p>
<p>Tests with ImKTx88 (from <italic>Isometrus masculatus</italic> scorpion venom) were
conducted with mice model of EAE to evaluate the toxin efficacy to prevent the
blood-brain barrier disruption and subsequent infiltration of auto-reactive
lymphocytes. This peptide was able to improve the severity of the disease and
stabilize the barrier by selectively blocking Kv1.3 channels, leading to changes in
expressions of adhesion molecules, receptors and interleukins. This effect is known
as a recommendation of a possible therapy to multiple sclerosis [<xref ref-type="bibr" rid="B127">127</xref>, <xref ref-type="bibr" rid="B156">156</xref>].</p>
<p>HsTX1 and its analogs, PEG-HsTX1[R14A] and HsTX1[R14A] were able to reduce
inflammation in an active DTH model (Lewis rats) and in the pristine-induced
arthritis rat model (Dark Agouti rats) [<xref ref-type="bibr" rid="B124">124</xref>].</p>
<p>Likewise, peptide Vm24, from <italic>Vaejovis mexicanus smithi</italic> scorpion
venom, in murine models (female Lewis rats), was able to reduce the DTH reaction.
Further studies showed the high affinity of the toxin with human lymphocytes,
suggesting new experiments to determine possible clinical application [<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B157">157</xref>].</p>
<p>Kaliotoxin (from <italic>Androctonus mauretanicus mauretanicus</italic> scorpion
venom) was able to decrease T-cell activation, leading to a decreased bone
resorption when facing experimental periodontal disease in rat models. Thus, this
toxin works as a factor of bone protection, being considered a potential therapeutic
drug to prevent alveolar bone loss in humans [<xref ref-type="bibr" rid="B129">129</xref>, <xref ref-type="bibr" rid="B158">158</xref>, <xref ref-type="bibr" rid="B159">159</xref>].</p>
<p>Charybdotoxin (from <italic>Leiurus quinquestriatus hebraeus</italic> scorpion venom)
suppressed lymphocyte proliferation and interleukin-2 (IL-2) production in both
human and mice lymphocytes. However, because it is considered as a less-selective
inhibitor, it can cause adverse effects, such as decrease in prothrombinase activity
as well as exposure of phosphatidylserine (an outer surface membrane aggregating
factor), leading to predisposition to hemorrhage due to the consumption of
coagulation factors [<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B158">158</xref>, <xref ref-type="bibr" rid="B160">160</xref>, <xref ref-type="bibr" rid="B161">161</xref>].</p>
<p>Ts6 and Ts15 toxins (from <italic>Tityus serrulatus</italic> scorpion venom)
demonstrated suppressive effects on DTH in BALB/c mice paw tissue 24h post-toxin
challenge. DTH is a reaction mediated predominantly by skin-homing T<sub>EM</sub>
CD4<sup>+</sup>. Therefore, the study indicates that these toxins could be
promising candidates for autoimmune disease therapy [<xref ref-type="bibr" rid="B148">148</xref>].</p>
</sec>
<sec>
<title>Concluding remarks</title>
<p>The Kv1.3 channels had already proved their potential as a therapeutic target to
treat diseases, such as cancer and autoimmune diseases. Since Kv1.3 regulates
calcium signaling inside T<sub>EM</sub> cells, which were considered the major
actors in mediating chronic autoimmune response, molecules that present selectivity
and high affinity to this channel could be used to design novel immunosuppressive
drugs. A new medicine discovered from single venom could be seen as a gift by
nature. Scorpion toxins are known to be a great source of neurotoxins including
Kv1.3 blockers. With 68 promising Kv1.3 toxins’ blockers so far, it is evident that
new immunosuppressive therapeutic drugs can be obtained by scorpion venoms. However,
these molecules still need to be structurally improved (e.g. chemical modifications
to improve selectivity and reduce immunogenicity) before reach the market, besides
further <italic>in vivo</italic> and clinical studies.</p>
<sec>
<title>Abbreviations</title>
<p>ATP: adenosine triphosphate; Ca<sup>2+</sup>: calcium; CD25: interleukin-2
receptor alpha chain; CNS: central nervous system; CRAC:
calcium-release-activated-calcium channel; CTLA4: cytotoxic
T-lymphocyte-associated protein 4; DTH: delayed-type hypersensitivity; EAE:
experimental autoimmune encephalomyelitis; FoxO1: forkhead box protein O1;
GATA1: erythroid transcription factor; GYGD: glycine-tyrosine-glycine-aspartic
acid; IL-2: interleukin-2; IL-10: interleukin-10; InsP3R:
inositol-1,4,5-trisphosphate receptor; KCa: potassium channel activated by
calcium; KTx: potassium channel acting toxins; Kv: voltage-gated potassium
channels; Kv1: voltage-gated potassium channel type 1; Kv1.3: voltage-gated
potassium channel type 1.3; K<sup>+</sup>: potassium; MCU: mitochondrial
Ca<sup>2+</sup> uniporter; NK: natural killer; PSD-95: postsynaptic density
protein 95; PMCA: plasma membrane Ca<sup>2+</sup> ATPase; pSTAT5:
phosphospecific signal transducer and activator of transcription 5; SERCA:
sarco/endoplasmatic reticulum Ca<sup>2+</sup> ATPase; T<sub>CM</sub>: central
memory T cells; T<sub>EM</sub>: T-effector memory lymphocytes; TrKB: Tropomyosin
receptor kinase B; T<sub>RM</sub>: tissue resident memory T cells;
T<sub>SCM</sub>: stem memory T cells. </p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="other" id="fn1">
<p><bold>Availability of data and material:</bold> Not applicable.</p>
</fn>
<fn fn-type="other" id="fn5">
<p><bold>Ethics approval and consent to participate:</bold> Not applicable.</p>
</fn>
<fn fn-type="other" id="fn6">
<p><bold>Consent for publication:</bold> Not applicable.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn2">
<p><bold>Funding:</bold> Financial support of Fundação de Amparo à Pesquisa do Estado de São Paulo
(FAPESP), São Paulo Research Foundation, scholarships to ISO n. 2017/03580-9 and
n.2018/21233-7, and FAC n. 2017/14035-1 and 2018/14158-9). Also, this work was
supported in part by Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
(CAPES, Coordination for the Improvement of Higher Education Personnel) through
Programa Editoração CAPES (call n. 13/2016, grant n. 0722/2017, record n.
88881.142062/2017-01) and by Conselho Nacional de Desenvolvimento Científico e
Tecnológico (CNPq, The National Council for Scientific and Technological
Development) through Programa Editorial CNPq/CAPES (call n. 26/2017, grant n.
440954/2017-7 and call n.18/2018 grant n. 404770/2018-5) and Produtividade em
Desenvolvimento Tecnológico e Extensão Inovadora (scholarship to MBP,
n.307155/2017-0).</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lima</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pimenta</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Martin-Eauclaire</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zingali</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Rochat</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Animal toxins: State of the art - perspectives in Health and
Biotechnology</article-title>
<source/>J Venom Anim Toxins incl Trop Dis
          <year>2009</year>
<volume>15</volume>
<issue>3</issue>
<pub-id pub-id-type="doi">10.1590/S1678-91992009000300021</pub-id>
</element-citation>
</ref>
<ref id="B2">
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Peigneur</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tytgat</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Toxins in drug discovery and pharmacology</article-title>
<source/>Toxins
          <publisher-loc>Basel</publisher-loc>
<year>2018</year>
<volume>10</volume>
<issue>3</issue>
<comment>pii</comment>
<elocation-id>E126</elocation-id>
<pub-id pub-id-type="pmid">29547537</pub-id>
</element-citation>
</ref>
<ref id="B3">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Souza</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Goncalves</surname>
<given-names>BDC</given-names>
</name>
<name>
<surname>Gomez</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Vieira</surname>
<given-names>LB</given-names>
</name>
<name>
<surname>Ribeiro</surname>
<given-names>FM</given-names>
</name>
</person-group>
<article-title>Animal toxins as therapeutic tools to treat neurodegenerative
diseases</article-title>
<source/>Front Pharmacol
          <year>2018</year>
<volume>9</volume>
<elocation-id>145</elocation-id>
<pub-id pub-id-type="pmid">29527170</pub-id>
</element-citation>
</ref>
<ref id="B4">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Casewell</surname>
<given-names>NR</given-names>
</name>
<name>
<surname>Wuster</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Vonk</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Harrison</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Fry</surname>
<given-names>BG</given-names>
</name>
</person-group>
<article-title>Complex cocktails: the evolutionary novelty of
venoms</article-title>
<source/>Trends Ecol Evol
          <year>2013</year>
<volume>28</volume>
<issue>4</issue>
<fpage>219</fpage>
<lpage>229</lpage>
<pub-id pub-id-type="pmid">23219381</pub-id>
</element-citation>
</ref>
<ref id="B5">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Biscola</surname>
<given-names>NP</given-names>
</name>
<name>
<surname>Cartarozzi</surname>
<given-names>LP</given-names>
</name>
<name>
<surname>Ulian-Benitez</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Barbizan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Castro</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Spejo</surname>
<given-names>AB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Multiple uses of fibrin sealant for nervous system treatment
following injury and disease</article-title>
<source/>J Venom Anim Toxins incl Trop Dis
          <year>2017</year>
<volume>23</volume>
<issue>13</issue>
<pub-id pub-id-type="doi">10.1186/s40409-017-0103-1</pub-id>
</element-citation>
</ref>
<ref id="B6">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferreira</surname>
<given-names>RS</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>de Barros</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Abbade</surname>
<given-names>LPF</given-names>
</name>
<name>
<surname>Barraviera</surname>
<given-names>SRCS</given-names>
</name>
<name>
<surname>Silvares</surname>
<given-names>MRC</given-names>
</name>
<name>
<surname>de Pontes</surname>
<given-names>LG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Heterologous fibrin sealant derived from snake venom: from bench
to bedside - an overview</article-title>
<source/>J Venom Anim Toxins incl Trop Dis
          <year>2017</year>
<volume>23</volume>
<elocation-id>21</elocation-id>
<pub-id pub-id-type="doi">10.1186/s40409-017-0109-8</pub-id>
<pub-id pub-id-type="pmid">28396682</pub-id>
</element-citation>
</ref>
<ref id="B7">
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Takacs</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Nathan</surname>
<given-names>S</given-names>
</name>
</person-group>
<chapter-title>Animal venoms in medicine</chapter-title>
<source/>Encyclopedia of Toxicology
          <edition>3</edition>
<person-group person-group-type="editor">
<name>
<surname>Wexler</surname>
<given-names>P</given-names>
</name>
</person-group>
<publisher-name>Academic Press</publisher-name>
<year>2014</year>
<fpage>252</fpage>
<lpage>259</lpage>
</element-citation>
</ref>
<ref id="B8">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>da Mata</surname>
<given-names>ECG</given-names>
</name>
<name>
<surname>Mourão</surname>
<given-names>CBF</given-names>
</name>
<name>
<surname>Rangel</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>EF</given-names>
</name>
</person-group>
<article-title>Antiviral activity of animal venom peptides and related
compounds</article-title>
<source/>J Venom Anim Toxins incl Trop Dis
          <year>2017</year>
<volume>23</volume>
<elocation-id>3</elocation-id>
<pub-id pub-id-type="doi">10.1186/s40409-016-0089-0</pub-id>
<pub-id pub-id-type="pmid">28074089</pub-id>
</element-citation>
</ref>
<ref id="B9">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pucca</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Cerni</surname>
<given-names>FA</given-names>
</name>
<name>
<surname>Pinheiro</surname>
<given-names>EL</given-names>
<suffix>Junior </suffix>
</name>
<name>
<surname>Bordon Kde</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Amorim</surname>
<given-names>FG</given-names>
</name>
<name>
<surname>Cordeiro</surname>
<given-names>FA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Tityus serrulatus venom - a lethal cocktail</article-title>
<source/>Toxicon
          <year>2015</year>
<volume>108</volume>
<fpage>272</fpage>
<lpage>284</lpage>
<pub-id pub-id-type="pmid">26522893</pub-id>
</element-citation>
</ref>
<ref id="B10">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nencioni</surname>
<given-names>ALA</given-names>
</name>
<name>
<surname>Neto</surname>
<given-names>EB</given-names>
</name>
<name>
<surname>de Freitas</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Dorce</surname>
<given-names>VAC</given-names>
</name>
</person-group>
<article-title>Effects of Brazilian scorpion venoms on the central nervous
system</article-title>
<source/>J Venom Anim Toxins incl Trop Dis
          <year>2018</year>
<volume>24</volume>
<elocation-id>3</elocation-id>
<pub-id pub-id-type="doi">10.1186/s40409-018-0139-x</pub-id>
<pub-id pub-id-type="pmid">29410679</pub-id>
</element-citation>
</ref>
<ref id="B11">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Casella-Martins</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ayres</surname>
<given-names>LR</given-names>
</name>
<name>
<surname>Burin</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Morais</surname>
<given-names>FR</given-names>
</name>
<name>
<surname>Pereira</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Faccioli</surname>
<given-names>LH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Immunomodulatory activity of Tityus serrulatus scorpion venom on
human T lymphocytes</article-title>
<source/>J Venom Anim Toxins incl Trop Dis
          <year>2015</year>
<volume>21</volume>
<elocation-id>46</elocation-id>
<pub-id pub-id-type="pmid">26566386</pub-id>
</element-citation>
</ref>
<ref id="B12">
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Ye</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Z</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The scorpion toxin analogue BmKTX-D33H as a potential Kv1.3
channel-selective immunomodulator for autoimmune diseases</article-title>
<source/>Toxins
          <publisher-loc>Basel</publisher-loc>
<year>2016</year>
<volume>8</volume>
<issue>4</issue>
<elocation-id>115</elocation-id>
<pub-id pub-id-type="pmid">27104568</pub-id>
</element-citation>
</ref>
<ref id="B13">
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Bordon</surname>
<given-names>KCF</given-names>
</name>
<name>
<surname>Cologna</surname>
<given-names>CT</given-names>
</name>
<name>
<surname>Arantes</surname>
<given-names>EC</given-names>
</name>
</person-group>
<chapter-title>Scorpion Venom Research Around the World: Tityus
serrulatus</chapter-title>
<source/>Scorpion Venoms
          <person-group person-group-type="editor">
<name>
<surname>Gopalakrishnakone</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Possani</surname>
<given-names>LD</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>EF</given-names>
</name>
<name>
<surname>de la Vega</surname>
<given-names>RCR</given-names>
</name>
</person-group>
<volume>4</volume>
<publisher-loc>Netherlands</publisher-loc>
<publisher-name>Springer</publisher-name>
<year>2015</year>
<fpage>411</fpage>
<lpage>437</lpage>
</element-citation>
</ref>
<ref id="B14">
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Kuzmenkov</surname>
<given-names>AI</given-names>
</name>
<name>
<surname>Grishin</surname>
<given-names>EV</given-names>
</name>
<name>
<surname>Vassilevski</surname>
<given-names>AA</given-names>
</name>
</person-group>
<article-title>Diversity of potassium channel ligands: focus on scorpion
toxins</article-title>
<source/>Biochemistry
          <publisher-loc>Mosc</publisher-loc>
<year>2015</year>
<volume>80</volume>
<issue>13</issue>
<fpage>1764</fpage>
<lpage>1799</lpage>
<pub-id pub-id-type="pmid">26878580</pub-id>
</element-citation>
</ref>
<ref id="B15">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wickenden</surname>
<given-names>AD</given-names>
</name>
</person-group>
<article-title>K(+) channels as therapeutic drug targets</article-title>
<source/>Pharmacol Ther
          <year>2002</year>
<volume>94</volume>
<issue>1-2</issue>
<fpage>157</fpage>
<lpage>182</lpage>
<pub-id pub-id-type="pmid">12191600</pub-id>
</element-citation>
</ref>
<ref id="B16">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beeton</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pennington</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Wulff</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nugent</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Crossley</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Targeting effector memory T cells with a selective peptide
inhibitor of Kv1.3 channels for therapy of autoimmune
diseases</article-title>
<source/>Mol Pharmacol
          <year>2005</year>
<volume>67</volume>
<issue>4</issue>
<fpage>1369</fpage>
<lpage>1381</lpage>
<pub-id pub-id-type="pmid">15665253</pub-id>
</element-citation>
</ref>
<ref id="B17">
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Toxins targeting the Kv1.3 channel: potential immunomodulators
for autoimmune diseases</article-title>
<source/>Toxins
          <publisher-loc>Basel</publisher-loc>
<year>2015</year>
<volume>7</volume>
<issue>5</issue>
<fpage>1749</fpage>
<lpage>1764</lpage>
<pub-id pub-id-type="pmid">25996605</pub-id>
</element-citation>
</ref>
<ref id="B18">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beeton</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wulff</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Standifer</surname>
<given-names>NE</given-names>
</name>
<name>
<surname>Azam</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Mullen</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Pennington</surname>
<given-names>MW</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Kv1.3 channels are a therapeutic target for T cell-mediated
autoimmune diseases</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2006</year>
<volume>103</volume>
<issue>46</issue>
<fpage>17414</fpage>
<lpage>17419</lpage>
<pub-id pub-id-type="pmid">17088564</pub-id>
</element-citation>
</ref>
<ref id="B19">
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Prentis</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Pavasovic</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Norton</surname>
<given-names>RS</given-names>
</name>
</person-group>
<article-title>Sea anemones: quiet achievers in the field of peptide
toxins</article-title>
<source/>Toxins
          <publisher-loc>Basel</publisher-loc>
<year>2018</year>
<volume>10</volume>
<issue>1</issue>
<comment>pii</comment>
<elocation-id>E36</elocation-id>
<pub-id pub-id-type="pmid">29316700</pub-id>
</element-citation>
</ref>
<ref id="B20">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tarcha</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Chi</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Munoz-Elias</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Bailey</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Londono</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Upadhyay</surname>
<given-names>SK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Durable pharmacological responses from the peptide ShK-186, a
specific Kv1.3 channel inhibitor that suppresses T cell mediators of
autoimmune disease</article-title>
<source/>J Pharmacol Exp Ther
          <year>2012</year>
<volume>342</volume>
<issue>3</issue>
<fpage>642</fpage>
<lpage>653</lpage>
<pub-id pub-id-type="pmid">22637724</pub-id>
</element-citation>
</ref>
<ref id="B21">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Norton</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Chandy</surname>
<given-names>KG</given-names>
</name>
</person-group>
<article-title>Venom-derived peptide inhibitors of voltage-gated potassium
channels</article-title>
<source/>Neuropharmacology
          <year>2017</year>
<volume>127</volume>
<fpage>124</fpage>
<lpage>138</lpage>
<pub-id pub-id-type="pmid">28689025</pub-id>
</element-citation>
</ref>
<ref id="B22">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chandy</surname>
<given-names>KG</given-names>
</name>
<name>
<surname>Norton</surname>
<given-names>RS</given-names>
</name>
</person-group>
<article-title>Peptide blockers of Kv1.3 channels in T cells as therapeutics for
autoimmune disease</article-title>
<source/>Curr Opin Chem Biol
          <year>2017</year>
<volume>38</volume>
<fpage>97</fpage>
<lpage>107</lpage>
<pub-id pub-id-type="pmid">28412597</pub-id>
</element-citation>
</ref>
<ref id="B23">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matteson</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Deutsch</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>K channels in T lymphocytes: a patch clamp study using monoclonal
antibody adhesion</article-title>
<source/>Nature
          <year>1984</year>
<volume>307</volume>
<issue>5950</issue>
<fpage>468</fpage>
<lpage>471</lpage>
<pub-id pub-id-type="pmid">6320008</pub-id>
</element-citation>
</ref>
<ref id="B24">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cahalan</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Chandy</surname>
<given-names>KG</given-names>
</name>
<name>
<surname>DeCoursey</surname>
<given-names>TE</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>A voltage-gated potassium channel in human T
lymphocytes</article-title>
<source/>J Physiol
          <year>1985</year>
<volume>358</volume>
<fpage>197</fpage>
<lpage>237</lpage>
<pub-id pub-id-type="pmid">2580081</pub-id>
</element-citation>
</ref>
<ref id="B25">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gutman</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Chandy</surname>
<given-names>KG</given-names>
</name>
<name>
<surname>Grissmer</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lazdunski</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mckinnon</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Pardo</surname>
<given-names>LA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>International Union of Pharmacology. LIII. Nomenclature and
molecular relationships of voltage-gated potassium channels</article-title>
<source/>Pharmacol Rev
          <year>2005</year>
<volume>57</volume>
<issue>4</issue>
<fpage>473</fpage>
<lpage>508</lpage>
<pub-id pub-id-type="pmid">16382104</pub-id>
</element-citation>
</ref>
<ref id="B26">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teisseyre</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gasiorowska</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Michalak</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Voltage-gated potassium channels Kv1.3 - potentially new
molecular target in cancer diagnostics and therapy</article-title>
<source/>Adv Clin Exp Med
          <year>2015</year>
<volume>24</volume>
<issue>3</issue>
<fpage>517</fpage>
<lpage>524</lpage>
<pub-id pub-id-type="pmid">26467143</pub-id>
</element-citation>
</ref>
<ref id="B27">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Grady</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>SY</given-names>
</name>
</person-group>
<article-title>Molecular diversity and function of voltage-gated (Kv) potassium
channels in epithelial cells</article-title>
<source/>Int J Biochem Cell Biol
          <year>2005</year>
<volume>37</volume>
<issue>8</issue>
<fpage>1578</fpage>
<lpage>1594</lpage>
<pub-id pub-id-type="pmid">15882958</pub-id>
</element-citation>
</ref>
<ref id="B28">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chandy</surname>
<given-names>KG</given-names>
</name>
<name>
<surname>Strong</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Aiyar</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gutman</surname>
<given-names>GA</given-names>
</name>
</person-group>
<article-title>Structural and biochemical features of the Kv1.3 potassium
channel: an aid to guided drug design</article-title>
<source/>Cell Physiol Biochem
          <year>1997</year>
<volume>7</volume>
<fpage>135</fpage>
<lpage>147</lpage>
</element-citation>
</ref>
<ref id="B29">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choe</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Potassium channel structures</article-title>
<source/>Nat Rev Neurosci
          <year>2002</year>
<volume>3</volume>
<issue>2</issue>
<fpage>115</fpage>
<lpage>121</lpage>
<pub-id pub-id-type="pmid">11836519</pub-id>
</element-citation>
</ref>
<ref id="B30">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aiyar</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rizzi</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Gutman</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Chandy</surname>
<given-names>KG</given-names>
</name>
</person-group>
<article-title>The signature sequence of voltage-gated potassium channels
projects into the external vestibule</article-title>
<source/>J Biol Chem
          <year>1996</year>
<volume>271</volume>
<issue>49</issue>
<fpage>31013</fpage>
<lpage>31016</lpage>
<pub-id pub-id-type="pmid">8940091</pub-id>
</element-citation>
</ref>
<ref id="B31">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aiyar</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Withka</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Rizzi</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Singleton</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Andrews</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>W</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Topology of the pore-region of a K+ channel revealed by the
NMR-derived structures of scorpion toxins</article-title>
<source/>Neuron
          <year>1995</year>
<volume>15</volume>
<issue>5</issue>
<fpage>1169</fpage>
<lpage>1181</lpage>
<pub-id pub-id-type="pmid">7576659</pub-id>
</element-citation>
</ref>
<ref id="B32">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>SH</given-names>
</name>
</person-group>
<article-title>Modeling the binding of three toxins to the voltage-gated
potassium channel (Kv1.3)</article-title>
<source/>Biophys J
          <year>2011</year>
<volume>101</volume>
<issue>11</issue>
<fpage>2652</fpage>
<lpage>2660</lpage>
<pub-id pub-id-type="pmid">22261053</pub-id>
</element-citation>
</ref>
<ref id="B33">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Varga</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Gurrola-Briones</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Papp</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Rodriguez de la Vega</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Pedraza-Alva</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Tajhya</surname>
<given-names>RB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Vm24, a natural immunosuppressive peptide, potently and
selectively blocks Kv1.3 potassium channels of human T cells</article-title>
<source/>Mol Pharmacol
          <year>2012</year>
<volume>82</volume>
<issue>3</issue>
<fpage>372</fpage>
<lpage>382</lpage>
<pub-id pub-id-type="pmid">22622363</pub-id>
</element-citation>
</ref>
<ref id="B34">
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Cerni</surname>
<given-names>FA</given-names>
</name>
<name>
<surname>Pucca</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Peigneur</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cremonez</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Bordon</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Tytgat</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Electrophysiological characterization of Ts6 and Ts7, K⁺ channel
toxins isolated through an improved Tityus serrulatus venom purification
procedure</article-title>
<source/>Toxins
          <publisher-loc>Basel</publisher-loc>
<year>2014</year>
<volume>6</volume>
<issue>3</issue>
<fpage>892</fpage>
<lpage>913</lpage>
<pub-id pub-id-type="pmid">24590385</pub-id>
</element-citation>
</ref>
<ref id="B35">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lewis</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Cahalan</surname>
<given-names>MD</given-names>
</name>
</person-group>
<article-title>Potassium and calcium channels in lymphocytes</article-title>
<source/>Annu Rev Immunol
          <year>1995</year>
<volume>13</volume>
<fpage>623</fpage>
<lpage>653</lpage>
<pub-id pub-id-type="pmid">7612237</pub-id>
</element-citation>
</ref>
<ref id="B36">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kotecha</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Schlichter</surname>
<given-names>LC</given-names>
</name>
</person-group>
<article-title>A Kv1.5 to Kv1.3 switch in endogenous hippocampal microglia and a
role in proliferation</article-title>
<source/>J Neurosci
          <year>1999</year>
<volume>19</volume>
<issue>24</issue>
<fpage>10680</fpage>
<lpage>10693</lpage>
<pub-id pub-id-type="pmid">10594052</pub-id>
</element-citation>
</ref>
<ref id="B37">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cayabyab</surname>
<given-names>FS</given-names>
</name>
<name>
<surname>Khanna</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>OT</given-names>
</name>
<name>
<surname>Schlichter</surname>
<given-names>LC</given-names>
</name>
</person-group>
<article-title>Suppression of the rat microglia Kv1.3 current by src-family
tyrosine kinases and oxygen/glucose deprivation</article-title>
<source/>Eur J Neurosci
          <year>2000</year>
<volume>12</volume>
<issue>6</issue>
<fpage>1949</fpage>
<lpage>1960</lpage>
<pub-id pub-id-type="pmid">10886336</pub-id>
</element-citation>
</ref>
<ref id="B38">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wulff</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Castle</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Pardo</surname>
<given-names>LA</given-names>
</name>
</person-group>
<article-title>Voltage-gated potassium channels as therapeutic
targets</article-title>
<source/>Nat Rev Drug Discov
          <year>2009</year>
<volume>8</volume>
<issue>12</issue>
<fpage>982</fpage>
<lpage>1001</lpage>
<pub-id pub-id-type="pmid">19949402</pub-id>
</element-citation>
</ref>
<ref id="B39">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Serrano-Albarrás</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Estadella</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Cirera-Rocosa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Navarro-Pérez</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Felipe</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Kv1.3: a multifunctional channel with many pathological
implications</article-title>
<source/>Expert Opin Ther Targets
          <year>2018</year>
<volume>22</volume>
<issue>2</issue>
<fpage>101</fpage>
<lpage>105</lpage>
<pub-id pub-id-type="pmid">29258373</pub-id>
</element-citation>
</ref>
<ref id="B40">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zweifach</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>RS</given-names>
</name>
</person-group>
<article-title>Mitogen-regulated Ca2+ current of T lymphocytes is activated by
depletion of intracellular Ca2+ stores</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>1993</year>
<volume>90</volume>
<issue>13</issue>
<fpage>6295</fpage>
<lpage>6299</lpage>
<pub-id pub-id-type="pmid">8392195</pub-id>
</element-citation>
</ref>
<ref id="B41">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wulff</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Calabresi</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Allie</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Yun</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pennington</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Beeton</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The voltage-gated Kv1.3 K(+) channel in effector memory T cells
as new target for MS</article-title>
<source/>J Clin Invest
          <year>2003</year>
<volume>111</volume>
<issue>11</issue>
<fpage>1703</fpage>
<lpage>1713</lpage>
<pub-id pub-id-type="pmid">12782673</pub-id>
</element-citation>
</ref>
<ref id="B42">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Pennington</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Whartenby</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Calabresi</surname>
<given-names>PA</given-names>
</name>
</person-group>
<article-title>Characterization of the functional properties of the
voltage-gated potassium channel Kv1.3 in human CD4+ T
lymphocytes</article-title>
<source/>J Immunol
          <year>2007</year>
<volume>179</volume>
<issue>7</issue>
<fpage>4563</fpage>
<lpage>4570</lpage>
<pub-id pub-id-type="pmid">17878353</pub-id>
</element-citation>
</ref>
<ref id="B43">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gocke</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Knapp</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Rosenzweig</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Grishkan</surname>
<given-names>IV</given-names>
</name>
<name>
<surname>Baxi</surname>
<given-names>EG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Functional blockade of the voltage-gated potassium channel Kv1.3
mediates reversion of T effector to central memory lymphocytes through
SMAD3/p21cip1 signaling</article-title>
<source/>J Biol Chem
          <year>2012</year>
<volume>287</volume>
<issue>2</issue>
<fpage>1261</fpage>
<lpage>1268</lpage>
<pub-id pub-id-type="pmid">22110135</pub-id>
</element-citation>
</ref>
<ref id="B44">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cahalan</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Chandy</surname>
<given-names>KG</given-names>
</name>
</person-group>
<article-title>The functional network of ion channels in T
lymphocytes</article-title>
<source/>Immunol Rev
          <year>2009</year>
<volume>231</volume>
<issue>1</issue>
<fpage>59</fpage>
<lpage>87</lpage>
<pub-id pub-id-type="pmid">19754890</pub-id>
</element-citation>
</ref>
<ref id="B45">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duque</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gazula</surname>
<given-names>VR</given-names>
</name>
<name>
<surname>Kaczmarek</surname>
<given-names>LK</given-names>
</name>
</person-group>
<article-title>Expression of Kv1.3 potassium channels regulates density of
cortical interneurons</article-title>
<source/>Dev Neurobiol
          <year>2013</year>
<volume>73</volume>
<issue>11</issue>
<fpage>841</fpage>
<lpage>855</lpage>
<pub-id pub-id-type="pmid">23821603</pub-id>
</element-citation>
</ref>
<ref id="B46">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marom</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Levitan</surname>
<given-names>IB</given-names>
</name>
</person-group>
<article-title>State-dependent inactivation of the Kv3 potassium
channel</article-title>
<source/>Biophys J
          <year>1994</year>
<volume>67</volume>
<issue>2</issue>
<fpage>579</fpage>
<lpage>589</lpage>
<pub-id pub-id-type="pmid">7948675</pub-id>
</element-citation>
</ref>
<ref id="B47">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nicolaou</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Neumeier</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Steckly</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kucher</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Takimoto</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Conforti</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Localization of Kv1.3 channels in the immunological synapse
modulates the calcium response to antigen stimulation in T
lymphocytes</article-title>
<source/>J Immunol
          <year>2009</year>
<volume>183</volume>
<issue>10</issue>
<fpage>6296</fpage>
<lpage>6302</lpage>
<pub-id pub-id-type="pmid">19841189</pub-id>
</element-citation>
</ref>
<ref id="B48">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fadool</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Tucker</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Perkins</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Fasciani</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>RN</given-names>
</name>
<name>
<surname>Parsons</surname>
<given-names>AD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Kv1.3 channel gene-targeted deletion produces “Super-Smeller
Mice” with altered glomeruli, interacting scaffolding proteins, and
biophysics</article-title>
<source/>Neuron
          <year>2004</year>
<volume>41</volume>
<issue>3</issue>
<fpage>389</fpage>
<lpage>404</lpage>
<pub-id pub-id-type="pmid">14766178</pub-id>
</element-citation>
</ref>
<ref id="B49">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gocke</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Lebson</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Grishkan</surname>
<given-names>IV</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Whartenby</surname>
<given-names>KA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Kv1.3 deletion biases T cells toward an immunoregulatory
phenotype and renders mice resistant to autoimmune
encephalomyelitis</article-title>
<source/>J Immunol
          <year>2012</year>
<volume>188</volume>
<issue>12</issue>
<fpage>5877</fpage>
<lpage>5886</lpage>
<pub-id pub-id-type="pmid">22581856</pub-id>
</element-citation>
</ref>
<ref id="B50">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grishkan</surname>
<given-names>IV</given-names>
</name>
<name>
<surname>Tosi</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Bowman</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Harary</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Calabresi</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Gocke</surname>
<given-names>AR</given-names>
</name>
</person-group>
<article-title>Antigenic stimulation of Kv1.3-deficient Th cells gives rise to a
population of Foxp3-Independent T cells with suppressive
properties</article-title>
<source/>J Immunol
          <year>2015</year>
<volume>195</volume>
<issue>4</issue>
<fpage>1399</fpage>
<lpage>1407</lpage>
<pub-id pub-id-type="pmid">26150529</pub-id>
</element-citation>
</ref>
<ref id="B51">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chiang</surname>
<given-names>EY</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Jeet</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>WP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Potassium channels Kv1.3 and KCa3.1 cooperatively and
compensatorily regulate antigen-specific memory T cell
functions</article-title>
<source/>Nat Commun
          <year>2017</year>
<volume>8</volume>
<elocation-id>14644</elocation-id>
<pub-id pub-id-type="pmid">28248292</pub-id>
</element-citation>
</ref>
<ref id="B52">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tucker</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Overton</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Fadool</surname>
<given-names>DA</given-names>
</name>
</person-group>
<article-title>Diet-induced obesity resistance of Kv1.3-/- mice is olfactory
bulb dependent</article-title>
<source/>J Neuroendocrinol
          <year>2012</year>
<volume>24</volume>
<issue>8</issue>
<fpage>1087</fpage>
<lpage>1095</lpage>
<pub-id pub-id-type="pmid">22435906</pub-id>
</element-citation>
</ref>
<ref id="B53">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Koni</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Kaczmarek</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The voltage-gated potassium channel Kv1.3 regulates energy
homeostasis and body weight</article-title>
<source/>Hum Mol Genet
          <year>2003</year>
<volume>12</volume>
<issue>5</issue>
<fpage>551</fpage>
<lpage>559</lpage>
<pub-id pub-id-type="pmid">12588802</pub-id>
</element-citation>
</ref>
<ref id="B54">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tucker</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Cavallin</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Jean-Baptiste</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Biju</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Overton</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Pedarzani</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The olfactory bulb: a metabolic sensor of brain insulin and
glucose concentrations via a voltage-gated potassium channel</article-title>
<source/>Results Probl Cell Differ
          <year>2010</year>
<volume>52</volume>
<fpage>147</fpage>
<lpage>157</lpage>
<pub-id pub-id-type="pmid">20865378</pub-id>
</element-citation>
</ref>
<ref id="B55">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Hoffman</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Chelette</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Thiebaud</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Fadool</surname>
<given-names>DA</given-names>
</name>
</person-group>
<article-title>Elevated anxiety and impaired attention in super-smeller, Kv1.3
knockout mice</article-title>
<source/>Front Behav Neurosci
          <year>2018</year>
<volume>12</volume>
<elocation-id>49</elocation-id>
<pub-id pub-id-type="pmid">29615878</pub-id>
</element-citation>
</ref>
<ref id="B56">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koni</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Khanna</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Kaczmarek</surname>
<given-names>LK</given-names>
</name>
<name>
<surname>Schlichter</surname>
<given-names>LC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Compensatory anion currents in Kv1.3 channel-deficient
thymocytes</article-title>
<source/>J Biol Chem
          <year>2003</year>
<volume>278</volume>
<fpage>39443</fpage>
<lpage>39451</lpage>
<pub-id pub-id-type="pmid">12878608</pub-id>
</element-citation>
</ref>
<ref id="B57">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vaeth</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Feske</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Ion channelopathies of the immune system</article-title>
<source/>Curr Opin Immunol
          <year>2018</year>
<volume>52</volume>
<fpage>39</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="pmid">29635109</pub-id>
</element-citation>
</ref>
<ref id="B58">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>JB</given-names>
</name>
</person-group>
<article-title>Channelopathies</article-title>
<source/>Korean J Pediatr
          <year>2014</year>
<volume>57</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>18</lpage>
<pub-id pub-id-type="pmid">24578711</pub-id>
</element-citation>
</ref>
<ref id="B59">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grabbe</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Schwarz</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Immunoregulatory mechanisms involved in elicitation of allergic
contact hypersensitivity</article-title>
<source/>Immunol Today
          <year>1998</year>
<volume>19</volume>
<issue>1</issue>
<fpage>37</fpage>
<lpage>44</lpage>
<pub-id pub-id-type="pmid">9465487</pub-id>
</element-citation>
</ref>
<ref id="B60">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petukhova</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Duvic</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hordinsky</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Norris</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Price</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Shimomura</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genome-wide association study in alopecia areata implicates both
innate and adaptive immunity</article-title>
<source/>Nature
          <year>2010</year>
<volume>466</volume>
<fpage>113</fpage>
<lpage>117</lpage>
<pub-id pub-id-type="pmid">20596022</pub-id>
</element-citation>
</ref>
<ref id="B61">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gilhar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Landau</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Assy</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Ullmann</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shalaginov</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Serafimovich</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Transfer of alopecia areata in the human scalp graft/Prkdc(scid)
(SCID) mouse system is characterized by a TH1 response</article-title>
<source/>Clin Immunol
          <year>2003</year>
<volume>106</volume>
<issue>3</issue>
<fpage>181</fpage>
<lpage>187</lpage>
<pub-id pub-id-type="pmid">12706404</pub-id>
</element-citation>
</ref>
<ref id="B62">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gilhar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Shalaginov</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Assy</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Serafimovich</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kalish</surname>
<given-names>RS</given-names>
</name>
</person-group>
<article-title>Alopecia areata is a T-lymphocyte mediated autoimmune disease:
lesional human T-lymphocytes transfer alopecia areata to human skin grafts
on SCID mice</article-title>
<source/>J Investig Dermatol Symp Proc
          <year>1999</year>
<volume>4</volume>
<issue>3</issue>
<fpage>207</fpage>
<lpage>210</lpage>
</element-citation>
</ref>
<ref id="B63">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tian</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Patrikeev</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Ochoa</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Vargas</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Belanger</surname>
<given-names>KK</given-names>
</name>
<name>
<surname>Litvinov</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>NF-κB mediates mesenchymal transition, remodeling, and pulmonary
fibrosis in response to chronic inflammation by viral RNA
patterns</article-title>
<source/>Am J Respir Cell Mol Biol
          <year>2017</year>
<volume>56</volume>
<issue>4</issue>
<fpage>506</fpage>
<lpage>520</lpage>
<pub-id pub-id-type="pmid">27911568</pub-id>
</element-citation>
</ref>
<ref id="B64">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frieri</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Stampfl</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Systemic lupus erythematosus and atherosclerosis: review of the
literature</article-title>
<source/>Autoimmun Rev
          <year>2016</year>
<volume>15</volume>
<issue>1</issue>
<fpage>16</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="pmid">26299985</pub-id>
</element-citation>
</ref>
<ref id="B65">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>DeSantis</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Goding Sauer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Newman</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Jemal</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Breast cancer statistics, 2017, racial disparity in mortality by
state</article-title>
<source/>CA Cancer J Clin
          <year>2017</year>
<volume>67</volume>
<issue>6</issue>
<fpage>439</fpage>
<lpage>448</lpage>
<pub-id pub-id-type="pmid">28972651</pub-id>
</element-citation>
</ref>
<ref id="B66">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hallek</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Chronic lymphocytic leukemia: 2015 update on diagnosis, risk
stratification, and treatment</article-title>
<source/>Am J Hematol
          <year>2015</year>
<volume>90</volume>
<issue>5</issue>
<fpage>446</fpage>
<lpage>460</lpage>
<pub-id pub-id-type="pmid">25908509</pub-id>
</element-citation>
</ref>
<ref id="B67">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rozman</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Montserrat</surname>
<given-names>E</given-names>
</name>
</person-group>
<chapter-title>Chronic lymphocytic leukemia</chapter-title>
<source/>N Engl J Med
          <year>1995</year>
<volume>333</volume>
<issue>16</issue>
<fpage>1052</fpage>
<lpage>1057</lpage>
<pub-id pub-id-type="pmid">7675049</pub-id>
</element-citation>
</ref>
<ref id="B68">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marinho</surname>
<given-names>AWGB</given-names>
</name>
<name>
<surname>Penha</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Galvão</surname>
<given-names>TF</given-names>
</name>
</person-group>
<article-title>Prevalência de doença renal crônica em adultos no Brasil: revisão
sistemática da literatura</article-title>
<source/>Cad Saúde Colet
          <year>2017</year>
<volume>25</volume>
<issue>3</issue>
<fpage>379</fpage>
<lpage>388</lpage>
</element-citation>
</ref>
<ref id="B69">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Friedman</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Bryen</surname>
<given-names>DN</given-names>
</name>
</person-group>
<article-title>Web accessibility design recommendations for people with
cognitive disabilities</article-title>
<source/>Technol Disabil
          <year>2007</year>
<volume>19</volume>
<issue>4</issue>
<fpage>205</fpage>
<lpage>212</lpage>
</element-citation>
</ref>
<ref id="B70">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cho</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kirschner</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Hanauer</surname>
<given-names>SB</given-names>
</name>
</person-group>
<article-title>Confirmation of a susceptibility locus for Crohn’ disease on
chromosome 16</article-title>
<source/>Inflamm Bowel Dis
          <year>1997</year>
<volume>3</volume>
<issue>3</issue>
<fpage>186</fpage>
<lpage>190</lpage>
<pub-id pub-id-type="pmid">23282803</pub-id>
</element-citation>
</ref>
<ref id="B71">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lovett-Racke</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Trotter</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Lauber</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Perrin</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>June</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Racke</surname>
<given-names>MK</given-names>
</name>
</person-group>
<article-title>Decreased dependence of myelin basic protein-reactive T cells on
CD28-mediated costimulation in multiple sclerosis patients. A marker of
activated/memory T cells</article-title>
<source/>J Clin Invest
          <year>1998</year>
<volume>101</volume>
<issue>4</issue>
<fpage>725</fpage>
<lpage>730</lpage>
<pub-id pub-id-type="pmid">9466965</pub-id>
</element-citation>
</ref>
<ref id="B72">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bielanska</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hernández-Losa</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Moline</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Somoza</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ramón y Cajal</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Condom</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Differential expression of Kv1.3 and Kv1.5 voltage-dependent K+
channels in human skeletal muscle sarcomas</article-title>
<source/>Cancer Invest
          <year>2012</year>
<volume>30</volume>
<issue>3</issue>
<fpage>203</fpage>
<lpage>208</lpage>
<pub-id pub-id-type="pmid">22360360</pub-id>
</element-citation>
</ref>
<ref id="B73">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bernardi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Cichelero</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Vitolo</surname>
<given-names>MR</given-names>
</name>
</person-group>
<article-title>Comportamento de restrição alimentar e obesidade</article-title>
<source/>Rev Nutr
          <year>2005</year>
<volume>18</volume>
<issue>1</issue>
<fpage>85</fpage>
<lpage>93</lpage>
</element-citation>
</ref>
<ref id="B74">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Varambally</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dhanasekaran</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Barrette</surname>
<given-names>TR</given-names>
</name>
<name>
<surname>Kumar-Sinha</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sanda</surname>
<given-names>MG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The polycomb group protein EZH2 is involved in progression of
prostate cancer</article-title>
<source/>Nature
          <year>2002</year>
<volume>419</volume>
<issue>6907</issue>
<fpage>624</fpage>
<lpage>629</lpage>
<pub-id pub-id-type="pmid">12374981</pub-id>
</element-citation>
</ref>
<ref id="B75">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Christophers</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Psoriasis--epidemiology and clinical spectrum</article-title>
<source/>Clin Exp Dermatol
          <year>2001</year>
<volume>26</volume>
<issue>4</issue>
<fpage>314</fpage>
<lpage>320</lpage>
<pub-id pub-id-type="pmid">11422182</pub-id>
</element-citation>
</ref>
<ref id="B76">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anderson</surname>
<given-names>KO</given-names>
</name>
<name>
<surname>Bradley</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>LD</given-names>
</name>
<name>
<surname>McDaniel</surname>
<given-names>LK</given-names>
</name>
<name>
<surname>Wise</surname>
<given-names>CM</given-names>
</name>
</person-group>
<article-title>Rheumatoid arthritis: review of psychological factors related to
etiology, effects, and treatment</article-title>
<source/>Psychol Bull
          <year>1985</year>
<volume>98</volume>
<issue>2</issue>
<fpage>358</fpage>
<lpage>387</lpage>
<pub-id pub-id-type="pmid">3901066</pub-id>
</element-citation>
</ref>
<ref id="B77">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Viglietta</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Kent</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Orban</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hafler</surname>
<given-names>DA</given-names>
</name>
</person-group>
<article-title>GAD65-reactive T cells are activated in patients with autoimmune
type 1a diabetes</article-title>
<source/>J Clin Invest
          <year>2002</year>
<volume>109</volume>
<issue>7</issue>
<fpage>895</fpage>
<lpage>903</lpage>
<pub-id pub-id-type="pmid">11927616</pub-id>
</element-citation>
</ref>
<ref id="B78">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van den Ouweland</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Lemkes</surname>
<given-names>HH</given-names>
</name>
<name>
<surname>Ruitenbeek</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Sandkuijl</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>de Vijlder</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Struyvenberg</surname>
<given-names>PA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree
with maternally transmitted type II diabetes mellitus and
deafness</article-title>
<source/>Nat Genet
          <year>1992</year>
<volume>1</volume>
<issue>5</issue>
<fpage>368</fpage>
<lpage>371</lpage>
<pub-id pub-id-type="pmid">1284550</pub-id>
</element-citation>
</ref>
<ref id="B79">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lie</surname>
<given-names>JT</given-names>
</name>
</person-group>
<article-title>Diagnostic histopathology of major systemic and pulmonary
vasculitic syndromes</article-title>
<source/>Rheum Dis Clin North Am
          <year>1990</year>
<volume>16</volume>
<issue>2</issue>
<fpage>269</fpage>
<lpage>292</lpage>
<pub-id pub-id-type="pmid">1971725</pub-id>
</element-citation>
</ref>
<ref id="B80">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feske</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Calcium signalling in lymphocyte activation and
disease</article-title>
<source/>Nat Rev Immunol
          <year>2007</year>
<volume>7</volume>
<issue>9</issue>
<fpage>690</fpage>
<lpage>702</lpage>
<pub-id pub-id-type="pmid">17703229</pub-id>
</element-citation>
</ref>
<ref id="B81">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Timmerman</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Clipstone</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>SN</given-names>
</name>
<name>
<surname>Northrop</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Crabtree</surname>
<given-names>GR</given-names>
</name>
</person-group>
<article-title>Rapid shuttling of NF-AT in discrimination of Ca2+ signals and
immunosuppression</article-title>
<source/>Nature
          <year>1996</year>
<volume>383</volume>
<issue>6603</issue>
<fpage>837</fpage>
<lpage>840</lpage>
<pub-id pub-id-type="pmid">8893011</pub-id>
</element-citation>
</ref>
<ref id="B82">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lam</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wulff</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>The lymphocyte potassium channels Kv1.3 and KCa3.1 as targets for
immunosuppression</article-title>
<source/>Drug Dev Res
          <year>2011</year>
<volume>72</volume>
<issue>7</issue>
<fpage>573</fpage>
<lpage>584</lpage>
<pub-id pub-id-type="pmid">22241939</pub-id>
</element-citation>
</ref>
<ref id="B83">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Le Deist</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Hivroz</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Partiseti</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Buc</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Oleastro</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A primary T-cell immunodeficiency associated with defective
transmembrane calcium influx</article-title>
<source/>Blood
          <year>1995</year>
<volume>85</volume>
<issue>4</issue>
<fpage>1053</fpage>
<lpage>1062</lpage>
<pub-id pub-id-type="pmid">7531512</pub-id>
</element-citation>
</ref>
<ref id="B84">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feske</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Prakriya</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>RS</given-names>
</name>
</person-group>
<article-title>A severe defect in CRAC Ca2+ channel activation and altered K+
channel gating in T cells from immunodeficient patients</article-title>
<source/>J Exp Med
          <year>2005</year>
<volume>202</volume>
<issue>5</issue>
<fpage>651</fpage>
<lpage>662</lpage>
<pub-id pub-id-type="pmid">16147976</pub-id>
</element-citation>
</ref>
<ref id="B85">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farber</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Yudanin</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Restifo</surname>
<given-names>NP</given-names>
</name>
</person-group>
<article-title>Human memory T cells: generation, compartmentalization and
homeostasis</article-title>
<source/>Nat Rev Immunol
          <year>2014</year>
<volume>14</volume>
<issue>1</issue>
<fpage>24</fpage>
<lpage>35</lpage>
<pub-id pub-id-type="pmid">24336101</pub-id>
</element-citation>
</ref>
<ref id="B86">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghanshani</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wulff</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Rohm</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Neben</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gutman</surname>
<given-names>GA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Up-regulation of the IKCa1 potassium channel during T-cell
activation. Molecular mechanism and functional consequences</article-title>
<source/>J Biol Chem
          <year>2000</year>
<volume>275</volume>
<issue>47</issue>
<fpage>37137</fpage>
<lpage>37149</lpage>
<pub-id pub-id-type="pmid">10961988</pub-id>
</element-citation>
</ref>
<ref id="B87">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beeton</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Chandy</surname>
<given-names>KG</given-names>
</name>
</person-group>
<article-title>Potassium channels, memory T cells, and multiple
sclerosis</article-title>
<source/>Neuroscientist
          <year>2005</year>
<volume>11</volume>
<issue>6</issue>
<fpage>550</fpage>
<lpage>562</lpage>
<pub-id pub-id-type="pmid">16282596</pub-id>
</element-citation>
</ref>
<ref id="B88">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dolmetsch</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>RS</given-names>
</name>
</person-group>
<article-title>Calcium oscillations increase the efficiency and specificity of
gene expression</article-title>
<source/>Nature
          <year>1998</year>
<volume>392</volume>
<fpage>933</fpage>
<lpage>936</lpage>
<pub-id pub-id-type="pmid">9582075</pub-id>
</element-citation>
</ref>
<ref id="B89">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koo</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Blake</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Talento</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sirotina</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Blockade of the voltage-gated potassium channel Kv1.3 inhibits
immune responses in vivo</article-title>
<source/>J Immunol
          <year>1997</year>
<volume>158</volume>
<issue>11</issue>
<fpage>5120</fpage>
<lpage>5128</lpage>
<pub-id pub-id-type="pmid">9164927</pub-id>
</element-citation>
</ref>
<ref id="B90">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beeton</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wulff</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Barbaria</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Clot-Faybesse</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Pennington</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bernard</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Selective blockade of T lymphocyte K(+) channels ameliorates
experimental autoimmune encephalomyelitis, a model for multiple
sclerosis</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2001</year>
<volume>98</volume>
<issue>24</issue>
<fpage>13942</fpage>
<lpage>13947</lpage>
<pub-id pub-id-type="pmid">11717451</pub-id>
</element-citation>
</ref>
<ref id="B91">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiménez-Vargas</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Possani</surname>
<given-names>LD</given-names>
</name>
<name>
<surname>Luna-Ramírez</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Arthropod toxins acting on neuronal potassium
channels</article-title>
<source/>Neuropharmacology
          <year>2017</year>
<volume>127</volume>
<fpage>139</fpage>
<lpage>160</lpage>
<pub-id pub-id-type="pmid">28941737</pub-id>
</element-citation>
</ref>
<ref id="B92">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodríguez de la Vega</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Possani</surname>
<given-names>LD</given-names>
</name>
</person-group>
<article-title>Current views on scorpion toxins specific for
K+-channels</article-title>
<source/>Toxicon
          <year>2004</year>
<volume>43</volume>
<issue>8</issue>
<fpage>865</fpage>
<lpage>875</lpage>
<pub-id pub-id-type="pmid">15208019</pub-id>
</element-citation>
</ref>
<ref id="B93">
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Cremonez</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Maiti</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Peigneur</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cassoli</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Dutra</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Waelkens</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Structural and functional elucidation of peptide Ts11 shows
evidence of a novel subfamily of scorpion venom toxins</article-title>
<source/>Toxins
          <publisher-loc>Basel</publisher-loc>
<year>2016</year>
<volume>8</volume>
<issue>10</issue>
<comment>pii</comment>
<elocation-id>E288</elocation-id>
<pub-id pub-id-type="pmid">27706049</pub-id>
</element-citation>
</ref>
<ref id="B94">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tytgat</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chandy</surname>
<given-names>KG</given-names>
</name>
<name>
<surname>Garcia</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Gutman</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Martin-Eauclaire</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>van der Walt</surname>
<given-names>JJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A unified nomenclature for short-chain peptides isolated from
scorpion venoms: alpha-KTx molecular subfamilies</article-title>
<source/>Trends Pharmacol Sci
          <year>1999</year>
<volume>20</volume>
<issue>11</issue>
<fpage>444</fpage>
<lpage>447</lpage>
<pub-id pub-id-type="pmid">10542442</pub-id>
</element-citation>
</ref>
<ref id="B95">
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Kuzmenkov</surname>
<given-names>AI</given-names>
</name>
<name>
<surname>Krylov</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Chugunov</surname>
<given-names>AO</given-names>
</name>
<name>
<surname>Grishin</surname>
<given-names>EV</given-names>
</name>
<name>
<surname>Vassilevski</surname>
<given-names>AA</given-names>
</name>
</person-group>
<article-title>Kalium: a database of potassium channel toxins from scorpion
venom</article-title>
<source/>Database
          <publisher-loc>Oxford</publisher-loc>
<year>2016</year>
<volume>2016</volume>
</element-citation>
</ref>
<ref id="B96">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Norton</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Pennington</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Wulff</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Potassium channel blockade by the sea anemone toxin ShK for the
treatment of multiple sclerosis and other autoimmune
diseases</article-title>
<source/>Curr Med Chem
          <year>2004</year>
<volume>11</volume>
<issue>23</issue>
<fpage>3041</fpage>
<lpage>3052</lpage>
<pub-id pub-id-type="pmid">15578998</pub-id>
</element-citation>
</ref>
<ref id="B97">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abbas</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Belghazi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Abdel-Mottaleb</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Tytgat</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bougis</surname>
<given-names>PE</given-names>
</name>
<name>
<surname>Martin-Eauclaire</surname>
<given-names>MF</given-names>
</name>
</person-group>
<article-title>A new Kaliotoxin selective towards Kv1.3 and Kv1.2 but not Kv1.1
channels expressed in oocytes</article-title>
<source/>Biochem Biophys Res Commun
          <year>2008</year>
<volume>376</volume>
<issue>3</issue>
<fpage>525</fpage>
<lpage>530</lpage>
<pub-id pub-id-type="pmid">18804453</pub-id>
</element-citation>
</ref>
<ref id="B98">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>ZY</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>ZJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Structural basis of a potent peptide inhibitor designed for Kv1.3
channel, a therapeutic target of autoimmune disease</article-title>
<source/>J Biol Chem
          <year>2008</year>
<volume>283</volume>
<issue>27</issue>
<fpage>19058</fpage>
<lpage>19065</lpage>
<pub-id pub-id-type="pmid">18480054</pub-id>
</element-citation>
</ref>
<ref id="B99">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garcia</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Garcia-Calvo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hidalgo</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>A</given-names>
</name>
<name>
<surname>MacKinnon</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Purification and characterization of three inhibitors of
voltage-dependent K+ channels from Leiurus quinquestriatus var. hebraeus
venom</article-title>
<source/>Biochemistry
          <year>1994</year>
<volume>33</volume>
<issue>22</issue>
<fpage>6834</fpage>
<lpage>6839</lpage>
<pub-id pub-id-type="pmid">8204618</pub-id>
</element-citation>
</ref>
<ref id="B100">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anangi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Koshy</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Huq</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Beeton</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Chuang</surname>
<given-names>WJ</given-names>
</name>
<name>
<surname>King</surname>
<given-names>GF</given-names>
</name>
</person-group>
<article-title>Recombinant expression of margatoxin and agitoxin-2 in Pichia
pastoris: an efficient method for production of KV1.3 channel
blockers</article-title>
<source/>PLoS One
          <year>2012</year>
<volume>7</volume>
<issue>12</issue>
<elocation-id>e52965</elocation-id>
<pub-id pub-id-type="pmid">23300835</pub-id>
</element-citation>
</ref>
<ref id="B101">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bagdány</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Batista</surname>
<given-names>CV</given-names>
</name>
<name>
<surname>Valdez-Cruz</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Somodi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rodriguez de la Vega</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Licea</surname>
<given-names>AF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Anuroctoxin, a new scorpion toxin of the alpha-KTx 6 subfamily,
is highly selective for Kv1.3 over IKCa1 ion channels of human T
lymphocytes</article-title>
<source/>Mol Pharmacol
          <year>2005</year>
<volume>67</volume>
<issue>4</issue>
<fpage>1034</fpage>
<lpage>1044</lpage>
<pub-id pub-id-type="pmid">15615696</pub-id>
</element-citation>
</ref>
<ref id="B102">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mao</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Cloning and characterization of BmK86, a novel K+ -channel
blocker from scorpion venom</article-title>
<source/>Biochem Biophys Res Commun
          <year>2007</year>
<volume>360</volume>
<issue>4</issue>
<fpage>728</fpage>
<lpage>734</lpage>
<pub-id pub-id-type="pmid">17624312</pub-id>
</element-citation>
</ref>
<ref id="B103">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>ZY</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>YT</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>WS</given-names>
</name>
<name>
<surname>He</surname>
<given-names>YW</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Hg1, novel peptide inhibitor specific for Kv1.3 channels from
first scorpion kunitz-type potassium channel toxin family</article-title>
<source/>J Biol Chem
          <year>2012</year>
<volume>287</volume>
<issue>17</issue>
<fpage>13813</fpage>
<lpage>13821</lpage>
<pub-id pub-id-type="pmid">22354971</pub-id>
</element-citation>
</ref>
<ref id="B104">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Sabatier</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>De Waard</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Unusual binding mode of scorpion toxin BmKTX onto potassium
channels relies on its distribution of acidic residues</article-title>
<source/>Biochem Biophys Res Commun
          <year>2014</year>
<volume>447</volume>
<issue>1</issue>
<fpage>70</fpage>
<lpage>76</lpage>
<pub-id pub-id-type="pmid">24704423</pub-id>
</element-citation>
</ref>
<ref id="B105">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Peigneur</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Molecular diversity and functional evolution of scorpion
potassium channel toxins</article-title>
<source/>Mol Cell Proteomics
          <year>2011</year>
<volume>10</volume>
<issue>2</issue>
<comment>M110.002832</comment>
</element-citation>
</ref>
<ref id="B106">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Two dyad-free Shaker-type K⁺ channel blockers from scorpion
venom</article-title>
<source/>Toxicon
          <year>2012</year>
<volume>59</volume>
<issue>3</issue>
<fpage>402</fpage>
<lpage>407</lpage>
<pub-id pub-id-type="pmid">22239942</pub-id>
</element-citation>
</ref>
<ref id="B107">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Romi-Lebrun</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lebrun</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Martin-Eauclaire</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Ishiguro</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Escoubas</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>FQ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Purification, characterization, and synthesis of three novel
toxins from the Chinese scorpion Buthus martensi, which act on K+
channels</article-title>
<source/>Biochemistry
          <year>1997</year>
<volume>36</volume>
<issue>44</issue>
<fpage>13473</fpage>
<lpage>13482</lpage>
<pub-id pub-id-type="pmid">9354615</pub-id>
</element-citation>
</ref>
<ref id="B108">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kozminsky-Atias</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Somech</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Zilberberg</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Isolation of the first toxin from the scorpion Buthus occitanus
israelis showing preference for Shaker potassium channels</article-title>
<source/>FEBS Lett
          <year>2007</year>
<volume>581</volume>
<issue>13</issue>
<fpage>2478</fpage>
<lpage>2484</lpage>
<pub-id pub-id-type="pmid">17490656</pub-id>
</element-citation>
</ref>
<ref id="B109">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coronas</surname>
<given-names>FV</given-names>
</name>
<name>
<surname>de Roodt</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Portugal</surname>
<given-names>TO</given-names>
</name>
<name>
<surname>Zamudio</surname>
<given-names>FZ</given-names>
</name>
<name>
<surname>Batista</surname>
<given-names>CV</given-names>
</name>
<name>
<surname>Gómez-Lagunas</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Possani</surname>
<given-names>LD</given-names>
</name>
</person-group>
<article-title>Disulfide bridges and blockage of Shaker B K(+)-channels by
another butantoxin peptide purified from the Argentinean scorpion Tityus
trivittatus</article-title>
<source/>Toxicon
          <year>2003</year>
<volume>41</volume>
<issue>2</issue>
<fpage>173</fpage>
<lpage>179</lpage>
<pub-id pub-id-type="pmid">12565736</pub-id>
</element-citation>
</ref>
<ref id="B110">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pimenta</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Mansuelle</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Diniz</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Martin-Eauclaire</surname>
<given-names>MF</given-names>
</name>
</person-group>
<article-title>Covalent structure and some pharmacological features of native
and cleaved alpha-KTx12-1, a four disulfide-bridged toxin from Tityus
serrulatus venom</article-title>
<source/>J Pept Sci
          <year>2003</year>
<volume>9</volume>
<issue>2</issue>
<fpage>132</fpage>
<lpage>140</lpage>
<pub-id pub-id-type="pmid">12630699</pub-id>
</element-citation>
</ref>
<ref id="B111">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olamendi-Portugal</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Somodi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fernández</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Zamudio</surname>
<given-names>FZ</given-names>
</name>
<name>
<surname>Becerril</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Varga</surname>
<given-names>Z</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Novel alpha-KTx peptides from the venom of the scorpion
Centruroides elegans selectively blockade Kv1.3 over IKCa1 K+ channels of T
cells</article-title>
<source/>Toxicon
          <year>2005</year>
<volume>46</volume>
<issue>4</issue>
<fpage>418</fpage>
<lpage>429</lpage>
<pub-id pub-id-type="pmid">16026809</pub-id>
</element-citation>
</ref>
<ref id="B112">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grissmer</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>AN</given-names>
</name>
<name>
<surname>Aiyar</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hanson</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Mather</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Gutman</surname>
<given-names>GA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pharmacological characterization of five cloned voltage-gated K+
channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian
cell lines</article-title>
<source/>Mol Pharmacol
          <year>1994</year>
<volume>45</volume>
<issue>6</issue>
<fpage>1227</fpage>
<lpage>1234</lpage>
<pub-id pub-id-type="pmid">7517498</pub-id>
</element-citation>
</ref>
<ref id="B113">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jouirou</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Mosbah</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Visan</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Grissmer</surname>
<given-names>S</given-names>
</name>
<name>
<surname>M’Barek</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fajloun</surname>
<given-names>Z</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cobatoxin 1 from Centruroides noxius scorpion venom: chemical
synthesis, three-dimensional structure in solution, pharmacology and docking
on K+ channels</article-title>
<source/>Biochem J
          <year>2004</year>
<volume>377</volume>
<issue-part>1</issue-part>
<fpage>37</fpage>
<lpage>49</lpage>
<pub-id pub-id-type="pmid">14498829</pub-id>
</element-citation>
</ref>
<ref id="B114">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Corzo</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Papp</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Varga</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Barraza</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Espino-Solis</surname>
<given-names>PG</given-names>
</name>
<name>
<surname>Rodriguez de la Vega</surname>
<given-names>RC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A selective blocker of Kv1.2 and Kv1.3 potassium channels from
the venom of the scorpion Centruroides suffusus suffusus</article-title>
<source/>Biochem Pharmacol
          <year>2008</year>
<volume>76</volume>
<issue>9</issue>
<fpage>1142</fpage>
<lpage>1154</lpage>
<pub-id pub-id-type="pmid">18786511</pub-id>
</element-citation>
</ref>
<ref id="B115">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ding</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Discovery of three toxin peptides with Kv1.3 channel and IL-2
cytokine-inhibiting activities from Non-Buthidae scorpions, Chaerilus
tricostatus and Chaerilus tryznai</article-title>
<source/>Peptides
          <year>2017</year>
<volume>91</volume>
<fpage>13</fpage>
<lpage>19</lpage>
<pub-id pub-id-type="pmid">28300672</pub-id>
</element-citation>
</ref>
<ref id="B116">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xie</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Z</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification of a new specific Kv1.3 channel blocker, Ctri9577,
from the scorpion Chaerilus tricostatus</article-title>
<source/>Peptides
          <year>2012</year>
<volume>36</volume>
<issue>1</issue>
<fpage>94</fpage>
<lpage>99</lpage>
<pub-id pub-id-type="pmid">22580271</pub-id>
</element-citation>
</ref>
<ref id="B117">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Srairi-Abid</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Shahbazzadeh</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Chatti</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Mlayah-Bellalouna</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mejdoub</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Borchani</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Hemitoxin, the first potassium channel toxin from the venom of
the Iranian scorpion Hemiscorpius lepturus</article-title>
<source/>FEBS J
          <year>2008</year>
<volume>275</volume>
<issue>18</issue>
<fpage>4641</fpage>
<lpage>4650</lpage>
<pub-id pub-id-type="pmid">18699777</pub-id>
</element-citation>
</ref>
<ref id="B118">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoang</surname>
<given-names>AN</given-names>
</name>
<name>
<surname>Vo</surname>
<given-names>HD</given-names>
</name>
<name>
<surname>Vo</surname>
<given-names>NP</given-names>
</name>
<name>
<surname>Kudryashova</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Nekrasova</surname>
<given-names>OV</given-names>
</name>
<name>
<surname>Feofanov</surname>
<given-names>AV</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Vietnamese Heterometrus laoticus scorpion venom: evidence for
analgesic and anti-inflammatory activity and isolation of new polypeptide
toxin acting on Kv1.3 potassium channel</article-title>
<source/>Toxicon
          <year>2014</year>
<volume>77</volume>
<fpage>40</fpage>
<lpage>48</lpage>
<pub-id pub-id-type="pmid">24189292</pub-id>
</element-citation>
</ref>
<ref id="B119">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>ZY</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>DY</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>YT</given-names>
</name>
<name>
<surname>He</surname>
<given-names>YW</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>JP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Structural and functional diversity of acidic scorpion potassium
channel toxins</article-title>
<source/>PLoS One
          <year>2012</year>
<volume>7</volume>
<issue>4</issue>
<elocation-id>e35154</elocation-id>
<pub-id pub-id-type="pmid">22511981</pub-id>
</element-citation>
</ref>
<ref id="B120">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwartz</surname>
<given-names>EF</given-names>
</name>
<name>
<surname>Diego-Garcia</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Rodríguez de la Vega</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Possani</surname>
<given-names>LD</given-names>
</name>
</person-group>
<article-title>Transcriptome analysis of the venom gland of the Mexican scorpion
Hadrurus gertschi (Arachnida: Scorpiones)</article-title>
<source/>BMC Genomics
          <year>2007</year>
<volume>8</volume>
<elocation-id>119</elocation-id>
<pub-id pub-id-type="pmid">17506894</pub-id>
</element-citation>
</ref>
<ref id="B121">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>T</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>SdPI, the first functionally characterized Kunitz-type trypsin
inhibitor from scorpion venom</article-title>
<source/>PLoS One
          <year>2011</year>
<volume>6</volume>
<issue>11</issue>
<elocation-id>e27548</elocation-id>
<pub-id pub-id-type="pmid">22087336</pub-id>
</element-citation>
</ref>
<ref id="B122">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koschak</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bugianesi</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Mitterdorfer</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kaczorowski</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>Garcia</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Knaus</surname>
<given-names>HG</given-names>
</name>
</person-group>
<article-title>Subunit composition of brain voltage-gated potassium channels
determined by hongotoxin-1, a novel peptide derived from Centruroides
limbatus venom</article-title>
<source/>J Biol Chem
          <year>1998</year>
<volume>273</volume>
<issue>5</issue>
<fpage>2639</fpage>
<lpage>2644</lpage>
<pub-id pub-id-type="pmid">9446567</pub-id>
</element-citation>
</ref>
<ref id="B123">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Regaya</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Beeton</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ferrat</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Andreotti</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Darbon</surname>
<given-names>H</given-names>
</name>
<name>
<surname>De Waard</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Evidence for domain-specific recognition of SK and Kv channels by
MTX and HsTx1 scorpion toxins</article-title>
<source/>J Biol Chem
          <year>2004</year>
<volume>279</volume>
<fpage>55690</fpage>
<lpage>55696</lpage>
<pub-id pub-id-type="pmid">15498765</pub-id>
</element-citation>
</ref>
<ref id="B124">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tanner</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Tajhya</surname>
<given-names>RB</given-names>
</name>
<name>
<surname>Huq</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gehrmann</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Rodarte</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Atik</surname>
<given-names>MA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prolonged immunomodulation in inflammatory arthritis using the
selective Kv1.3 channel blocker HsTX1[R14A] and its PEGylated
analog</article-title>
<source/>Clin Immunol
          <year>2017</year>
<volume>180</volume>
<fpage>45</fpage>
<lpage>57</lpage>
<pub-id pub-id-type="pmid">28389388</pub-id>
</element-citation>
</ref>
<ref id="B125">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>ImKTx1, a new Kv1.3 channel blocker with a unique primary
structure</article-title>
<source/>J Biochem Mol Toxicol
          <year>2011</year>
<volume>25</volume>
<issue>4</issue>
<fpage>244</fpage>
<lpage>251</lpage>
<pub-id pub-id-type="pmid">21308893</pub-id>
</element-citation>
</ref>
<ref id="B126">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Yi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>ImKTx88, a novel selective Kv1.3 channel blocker derived from the
scorpion Isometrus maculates</article-title>
<source/>Toxicon
          <year>2011</year>
<volume>57</volume>
<issue>2</issue>
<fpage>348</fpage>
<lpage>355</lpage>
<pub-id pub-id-type="pmid">21194541</pub-id>
</element-citation>
</ref>
<ref id="B127">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>X</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Kv1.3 channel blocker (ImKTx88) maintains blood-brain barrier in
experimental autoimmune encephalomyelitis</article-title>
<source/>Cell Biosci
          <year>2017</year>
<volume>7</volume>
<elocation-id>31</elocation-id>
<pub-id pub-id-type="pmid">28596825</pub-id>
</element-citation>
</ref>
<ref id="B128">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shijin</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yibao</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zongyun</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yingliang</surname>
<given-names>W</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Characterization of a new Kv1.3 channel-specific blocker, J123,
from the scorpion Buthus martensii Karsch</article-title>
<source/>Peptides
          <year>2008</year>
<volume>29</volume>
<issue>9</issue>
<fpage>1514</fpage>
<lpage>1520</lpage>
<pub-id pub-id-type="pmid">18571286</pub-id>
</element-citation>
</ref>
<ref id="B129">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valverde</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kawai</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Taubman</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Selective blockade of voltage-gated potassium channels reduces
inflammatory bone resorption in experimental periodontal
disease</article-title>
<source/>J Bone Miner Res
          <year>2004</year>
<volume>19</volume>
<issue>1</issue>
<fpage>155</fpage>
<lpage>164</lpage>
<pub-id pub-id-type="pmid">14753747</pub-id>
</element-citation>
</ref>
<ref id="B130">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mahjoubi-Boubaker</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Crest</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Khalifa</surname>
<given-names>RB</given-names>
</name>
<name>
<surname>El Ayeb</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kharrat</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Kbot1, a three disulfide bridges toxin from Buthus occitanus
tunetanus venom highly active on both SK and Kv channels</article-title>
<source/>Peptides
          <year>2004</year>
<volume>25</volume>
<issue>4</issue>
<fpage>637</fpage>
<lpage>645</lpage>
<pub-id pub-id-type="pmid">15165720</pub-id>
</element-citation>
</ref>
<ref id="B131">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Srinivasan</surname>
<given-names>KN</given-names>
</name>
<name>
<surname>Sivaraja</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Huys</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Sasaki</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>TK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>kappa-Hefutoxin1, a novel toxin from the scorpion Heterometrus
fulvipes with unique structure and function. Importance of the functional
diad in potassium channel selectivity</article-title>
<source/>J Biol Chem
          <year>2002</year>
<volume>277</volume>
<issue>33</issue>
<fpage>30040</fpage>
<lpage>30047</lpage>
<pub-id pub-id-type="pmid">12034709</pub-id>
</element-citation>
</ref>
<ref id="B132">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bayrhuber</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vijayan</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Ferber</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Graf</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Korukottu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Imperial</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Conkunitzin-S1 is the first member of a new Kunitz-type
neurotoxin family. Structural and functional
characterization</article-title>
<source/>J Biol Chem
          <year>2005</year>
<volume>280</volume>
<issue>25</issue>
<fpage>23766</fpage>
<lpage>23770</lpage>
<pub-id pub-id-type="pmid">15833744</pub-id>
</element-citation>
</ref>
<ref id="B133">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Molecular cloning and functional identification of a new K(+)
channel blocker, LmKTx10, from the scorpion Lychas
mucronatus</article-title>
<source/>Peptides
          <year>2009</year>
<volume>30</volume>
<issue>4</issue>
<fpage>675</fpage>
<lpage>680</lpage>
<pub-id pub-id-type="pmid">19103241</pub-id>
</element-citation>
</ref>
<ref id="B134">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>YL</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gan</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Molecular cloning and electrophysiological studies on the first
K(+) channel toxin (LmKTx8) derived from scorpion Lychas
mucronatus</article-title>
<source/>Peptides
          <year>2007</year>
<volume>28</volume>
<fpage>2306</fpage>
<lpage>2312</lpage>
<pub-id pub-id-type="pmid">18006119</pub-id>
</element-citation>
</ref>
<ref id="B135">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garcia-Calvo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Leonard</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Novick</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Stevens</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Schmalhofer</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Kaczorowski</surname>
<given-names>GJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Purification, characterization, and biosynthesis of margatoxin, a
component of Centruroides margaritatus venom that selectively inhibits
voltage-dependent potassium channels</article-title>
<source/>J Biol Chem
          <year>1993</year>
<volume>268</volume>
<issue>25</issue>
<fpage>18866</fpage>
<lpage>18874</lpage>
<pub-id pub-id-type="pmid">8360176</pub-id>
</element-citation>
</ref>
<ref id="B136">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jang</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Ryu</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>SY</given-names>
</name>
</person-group>
<article-title>Anti-proliferative effect of Kv1.3 blockers in A549 human lung
adenocarcinoma in vitro and in vivo</article-title>
<source/>Eur J Pharmacol
          <year>2011</year>
<volume>651</volume>
<issue>1-3</issue>
<fpage>26</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="pmid">21087602</pub-id>
</element-citation>
</ref>
<ref id="B137">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diego-Garcia</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Peigneur</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Debaveye</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gheldof</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Tytgat</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Caliskan</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Novel potassium channel blocker venom peptides from Mesobuthus
gibbosus (Scorpiones: Buthidae)</article-title>
<source/>Toxicon
          <year>2013</year>
<volume>61</volume>
<fpage>72</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="pmid">23142506</pub-id>
</element-citation>
</ref>
<ref id="B138">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Peigneur</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tytgat</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>A potent potassium channel blocker from Mesobuthus eupeus
scorpion venom</article-title>
<source/>Biochimie
          <year>2010</year>
<volume>92</volume>
<issue>12</issue>
<fpage>1847</fpage>
<lpage>1853</lpage>
<pub-id pub-id-type="pmid">20713119</pub-id>
</element-citation>
</ref>
<ref id="B139">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Peigneur</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dalziel</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tytgat</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Molecular divergence of two orthologous scorpion toxins affecting
potassium channels</article-title>
<source/>Comp Biochem Physiol A Mol Integr Physiol
          <year>2011</year>
<volume>159</volume>
<issue>3</issue>
<comment>313-21</comment>
</element-citation>
</ref>
<ref id="B140">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwartz</surname>
<given-names>EF</given-names>
</name>
<name>
<surname>Bartok</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Papp</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Gómez-Lagunas</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Panyi</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>OcyKTx2, a new K⁺-channel toxin characterized from the venom of
the scorpion Opisthacanthus cayaporum</article-title>
<source/>Peptides
          <year>2013</year>
<volume>46</volume>
<fpage>40</fpage>
<lpage>46</lpage>
<pub-id pub-id-type="pmid">23684923</pub-id>
</element-citation>
</ref>
<ref id="B141">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abdel-Mottaleb</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Vandendriessche</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Clynen</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Landuyt</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Jalali</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vatanpour</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>OdK2, a Kv1.3 channel-selective toxin from the venom of the
Iranian scorpion Odonthobuthus doriae</article-title>
<source/>Toxicon
          <year>2008</year>
<volume>51</volume>
<issue>8</issue>
<fpage>1424</fpage>
<lpage>1430</lpage>
<pub-id pub-id-type="pmid">18471844</pub-id>
</element-citation>
</ref>
<ref id="B142">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chagot</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Pimentel</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Pil</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tytgat</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Nakajima</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>An unusual fold for potassium channel blockers: NMR structure of
three toxins from the scorpion Opisthacanthus
madagascariensis</article-title>
<source/>Biochem J
          <year>2005</year>
<volume>388</volume>
<issue-part>1</issue-part>
<fpage>263</fpage>
<lpage>271</lpage>
<pub-id pub-id-type="pmid">15631621</pub-id>
</element-citation>
</ref>
<ref id="B143">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mouhat</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Visan</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Ananthakrishnan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wulff</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Andreotti</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Grissmer</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>K+ channel types targeted by synthetic OSK1, a toxin from
Orthochirus scrobiculosus scorpion venom</article-title>
<source/>Biochem J
          <year>2005</year>
<volume>385</volume>
<issue-part>1</issue-part>
<fpage>95</fpage>
<lpage>104</lpage>
<pub-id pub-id-type="pmid">15588251</pub-id>
</element-citation>
</ref>
<ref id="B144">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huys</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Dyason</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Waelkens</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Verdonck</surname>
<given-names>F</given-names>
</name>
<name>
<surname>van Zyl</surname>
<given-names>J</given-names>
</name>
<name>
<surname>du Plessis</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Purification, characterization and biosynthesis of parabutoxin 3,
a component of Parabuthus transvaalicus venom</article-title>
<source/>Eur J Biochem
          <year>2002</year>
<volume>269</volume>
<issue>7</issue>
<fpage>1854</fpage>
<lpage>1865</lpage>
<pub-id pub-id-type="pmid">11952787</pub-id>
</element-citation>
</ref>
<ref id="B145">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Péter</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Varga</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Panyi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Bene</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Damjanovich</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pieri</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pandinus imperator scorpion venom blocks voltage-gated K+
channels in human lymphocytes</article-title>
<source/>Biochem Biophys Res Commun
          <year>1998</year>
<volume>242</volume>
<issue>3</issue>
<fpage>621</fpage>
<lpage>625</lpage>
<pub-id pub-id-type="pmid">9464266</pub-id>
</element-citation>
</ref>
<ref id="B146">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Batista</surname>
<given-names>CV</given-names>
</name>
<name>
<surname>Gomez-Lagunas</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Rodriguez de la Vega</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Hajdu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Panyi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Gaspar</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Two novel toxins from the Amazonian scorpion Tityus cambridgei
that block Kv1.3 and Shaker B K(+)-channels with distinctly different
affinities</article-title>
<source/>Biochim Biophys Acta
          <year>2002</year>
<volume>1601</volume>
<issue>2</issue>
<fpage>123</fpage>
<lpage>131</lpage>
<pub-id pub-id-type="pmid">12445473</pub-id>
</element-citation>
</ref>
<ref id="B147">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cologna</surname>
<given-names>CT</given-names>
</name>
<name>
<surname>Peigneur</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rosa</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Selistre-de-Araujo</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Varanda</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Tytgat</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Purification and characterization of Ts15, the first member of a
new alpha-KTX subfamily from the venom of the Brazilian scorpion Tityus
serrulatus</article-title>
<source/>Toxicon
          <year>2011</year>
<volume>58</volume>
<issue>1</issue>
<fpage>54</fpage>
<lpage>61</lpage>
<pub-id pub-id-type="pmid">21600910</pub-id>
</element-citation>
</ref>
<ref id="B148">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pucca</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Bertolini</surname>
<given-names>TB</given-names>
</name>
<name>
<surname>Cerni</surname>
<given-names>FA</given-names>
</name>
<name>
<surname>Bordon</surname>
<given-names>KCF</given-names>
</name>
<name>
<surname>Peigneur</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tytgat</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Immunosuppressive evidence of Tityus serrulatus toxins Ts6 and
Ts15: insights of a novel K(+) channel pattern in T cells</article-title>
<source/>Immunology
          <year>2016</year>
<volume>147</volume>
<issue>2</issue>
<fpage>240</fpage>
<lpage>250</lpage>
<pub-id pub-id-type="pmid">26595158</pub-id>
</element-citation>
</ref>
<ref id="B149">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Papp</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Batista</surname>
<given-names>CV</given-names>
</name>
<name>
<surname>Varga</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Herceg</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Román-González</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Gaspar</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Tst26, a novel peptide blocker of Kv1.2 and Kv1.3 channels from
the venom of Tityus stigmurus</article-title>
<source/>Toxicon
          <year>2009</year>
<volume>54</volume>
<issue>4</issue>
<fpage>379</fpage>
<lpage>389</lpage>
<pub-id pub-id-type="pmid">19500613</pub-id>
</element-citation>
</ref>
<ref id="B150">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abdel-Mottaleb</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Coronas</surname>
<given-names>FV</given-names>
</name>
<name>
<surname>de Roodt</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Possani</surname>
<given-names>LD</given-names>
</name>
<name>
<surname>Tytgat</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>A novel toxin from the venom of the scorpion Tityus trivittatus,
is the first member of a new alpha-KTX subfamily</article-title>
<source/>FEBS Lett
          <year>2006</year>
<volume>580</volume>
<issue>2</issue>
<fpage>592</fpage>
<lpage>596</lpage>
<pub-id pub-id-type="pmid">16405970</pub-id>
</element-citation>
</ref>
<ref id="B151">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luna-Ramírez</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bartok</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Restano-Cassulini</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Quintero-Hernández</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Coronas</surname>
<given-names>FI</given-names>
</name>
<name>
<surname>Christensen</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Structure, molecular modeling, and function of the novel
potassium channel blocker urotoxin isolated from the venom of the Australian
scorpion Urodacus yaschenkoi</article-title>
<source/>Mol Pharmacol
          <year>2014</year>
<volume>86</volume>
<issue>1</issue>
<fpage>28</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="pmid">24723491</pub-id>
</element-citation>
</ref>
<ref id="B152">
<element-citation publication-type="other">
<person-group person-group-type="author">
<name>
<surname>Postay</surname>
<given-names>LDP</given-names>
</name>
<name>
<surname>Gurrola-Briones</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Salas-Castillo</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Ferreira</surname>
<given-names>BCV</given-names>
</name>
<name>
<surname>Varga</surname>
<given-names>ZS</given-names>
</name>
<name>
<surname>Panyi</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<source/>Vm23 and Vm24, two scorpion peptides that block human t-lymphocyte
potassium channels (sub-type kv1.3) with high selectivity and decrease the
<italic toggle="yes">in vivo</italic> dth-responses in rats
          <year>2007</year>
</element-citation>
</ref>
<ref id="B153">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Becchetti</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Ion channels and transporters in cancer. 1. Ion channels and cell
proliferation in cancer</article-title>
<source/>Am J Physiol Cell Physiol
          <year>2011</year>
<volume>301</volume>
<issue>2</issue>
<fpage>C255</fpage>
<lpage>C265</lpage>
<pub-id pub-id-type="pmid">21430288</pub-id>
</element-citation>
</ref>
<ref id="B154">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feske</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wulff</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Skolnik</surname>
<given-names>EY</given-names>
</name>
</person-group>
<article-title>Ion channels in innate and adaptive immunity</article-title>
<source/>Annu Rev Immunol
          <year>2015</year>
<volume>33</volume>
<fpage>291</fpage>
<lpage>353</lpage>
<pub-id pub-id-type="pmid">25861976</pub-id>
</element-citation>
</ref>
<ref id="B155">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rashid</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Huq</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Tanner</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Chhabra</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Khoo</surname>
<given-names>KK</given-names>
</name>
<name>
<surname>Estrada</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A potent and Kv1.3-selective analogue of the scorpion toxin HsTX1
as a potential therapeutic for autoimmune diseases</article-title>
<source/>Sci Rep
          <year>2014</year>
<volume>4</volume>
<elocation-id>4509</elocation-id>
<pub-id pub-id-type="pmid">24676092</pub-id>
</element-citation>
</ref>
<ref id="B156">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Yi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>ImKTx88, a novel selective Kv1.3 channel blocker derived from the
scorpion Isometrus maculatus</article-title>
<source/>Toxicon
          <year>2011</year>
<volume>57</volume>
<issue>2</issue>
<fpage>348</fpage>
<lpage>355</lpage>
<pub-id pub-id-type="pmid">21194541</pub-id>
</element-citation>
</ref>
<ref id="B157">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gurrola</surname>
<given-names>GB</given-names>
</name>
<name>
<surname>Hernández-López</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Rodríguez de la Vega</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Varga</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Batista</surname>
<given-names>CV</given-names>
</name>
<name>
<surname>Salas-Castillo</surname>
<given-names>SP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Structure, function, and chemical synthesis of Vaejovis mexicanus
peptide 24: a novel potent blocker of Kv1.3 potassium channels of human T
lymphocytes</article-title>
<source/>Biochemistry
          <year>2012</year>
<volume>51</volume>
<issue>19</issue>
<fpage>4049</fpage>
<lpage>4061</lpage>
<pub-id pub-id-type="pmid">22540187</pub-id>
</element-citation>
</ref>
<ref id="B158">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hmed</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Serria</surname>
<given-names>HT</given-names>
</name>
<name>
<surname>Mounir</surname>
<given-names>ZK</given-names>
</name>
</person-group>
<article-title>Scorpion peptides: potential use for new drug
development</article-title>
<source/>J Toxicol
          <year>2013</year>
<volume>2013</volume>
<elocation-id>958797</elocation-id>
<pub-id pub-id-type="pmid">23843786</pub-id>
</element-citation>
</ref>
<ref id="B159">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crest</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jacquet</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Gola</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zerrouk</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Benslimane</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rochat</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Kaliotoxin, a novel peptidyl inhibitor of neuronal BK-type
Ca(2+)-activated K+ channels characterized from Androctonus mauretanicus
mauretanicus venom</article-title>
<source/>J Biol Chem
          <year>1992</year>
<volume>267</volume>
<issue>3</issue>
<fpage>1640</fpage>
<lpage>1647</lpage>
<pub-id pub-id-type="pmid">1730708</pub-id>
</element-citation>
</ref>
<ref id="B160">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thell</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hellinger</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Schabbauer</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Gruber</surname>
<given-names>CW</given-names>
</name>
</person-group>
<article-title>Immunosuppressive peptides and their therapeutic
applications</article-title>
<source/>Drug Discov Today
          <year>2014</year>
<volume>19</volume>
<issue>5</issue>
<fpage>645</fpage>
<lpage>653</lpage>
<pub-id pub-id-type="pmid">24333193</pub-id>
</element-citation>
</ref>
<ref id="B161">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gimenez-Gallego</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Navia</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Reuben</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Katz</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Kaczorowski</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>Garcia</surname>
<given-names>ML</given-names>
</name>
</person-group>
<article-title>Purification, sequence, and model structure of charybdotoxin, a
potent selective inhibitor of calcium-activated potassium
channels</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>1988</year>
<volume>85</volume>
<issue>10</issue>
<fpage>3329</fpage>
<lpage>3333</lpage>
<pub-id pub-id-type="pmid">2453055</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>